ms-val-0 1 5 Culture tests indicate Trichomonas vaginalis. ms-val-0 1 5 Culture tests indicate Trichomonas vaginalis. ms-val-0 1 5 Culture tests indicate Trichomonas vaginalis.
ms-val-1 1 -1 nan ms-val-1 1 -1 nan ms-val-1 1 -1 nan
ms-val-2 1 24 Pathology confirms Mycoplasma pneumoniae is the causal organism. ms-val-2 1 24 Pathology confirms Mycoplasma pneumoniae is the causal organism. ms-val-2 1 24 Pathology confirms Mycoplasma pneumoniae is the causal organism.
ms-val-3 1 4 Laboratory studies confirm that he has parainfluenza virus. ms-val-3 1 4 Laboratory studies confirm that he has parainfluenza virus. ms-val-3 1 4 Laboratory studies confirm that he has parainfluenza virus.
ms-val-4 1 0 A previously healthy 25-year-old man comes to the physician with a suspected Chlamydia trachomatis infection because of a 1-week history of fever and fluid release from painful lumps in his right groin. ms-val-4 1 0 A previously healthy 25-year-old man comes to the physician with a suspected Chlamydia trachomatis infection because of a 1-week history of fever and fluid release from painful lumps in his right groin. ms-val-4 1 0 A previously healthy 25-year-old man comes to the physician with a suspected Chlamydia trachomatis infection because of a 1-week history of fever and fluid release from painful lumps in his right groin.
ms-val-5 1 -1 nan ms-val-5 1 -1 nan ms-val-5 1 -1 nan
ms-val-6 1 6 The patient has a Salmonella typhi infection. ms-val-6 1 6 The patient has a Salmonella typhi infection. ms-val-6 1 6 The patient has a Salmonella typhi infection.
ms-val-7 1 -1 nan ms-val-7 1 -1 nan ms-val-7 1 -1 nan
ms-val-8 1 12 Suspected of picornavirus. ms-val-8 1 12 Suspected of picornavirus. ms-val-8 1 12 Suspected of picornavirus.
ms-val-9 1 -1 nan ms-val-9 1 -1 nan ms-val-9 1 -1 nan
ms-val-10 1 10 The causal organism is Staphylococcus epidermidis. ms-val-10 1 10 The causal organism is Staphylococcus epidermidis. ms-val-10 1 10 The causal organism is Staphylococcus epidermidis.
ms-val-11 1 -1 nan ms-val-11 1 -1 nan ms-val-11 1 -1 nan
ms-val-12 1 11 After reviewing labs and biopsy results, human herpesvirus 8 was determined to be the causal organism. ms-val-12 1 11 After reviewing labs and biopsy results, human herpesvirus 8 was determined to be the causal organism. ms-val-12 1 11 After reviewing labs and biopsy results, human herpesvirus 8 was determined to be the causal organism.
ms-val-13 1 -1 nan ms-val-13 1 -1 nan ms-val-13 1 -1 nan
ms-val-14 1 13 Pathology reports indicate infection by Chlamydia trachomatis. ms-val-14 1 13 Pathology reports indicate infection by Chlamydia trachomatis. ms-val-14 1 13 Pathology reports indicate infection by Chlamydia trachomatis.
ms-val-15 1 -1 nan ms-val-15 1 -1 nan ms-val-15 1 -1 nan
ms-val-16 1 7 An Ehrlichia chaffeensis infection is confirmed after a peripheral blood smear shows monocytes with intracytoplasmic morulae. ms-val-16 1 7 An Ehrlichia chaffeensis infection is confirmed after a peripheral blood smear shows monocytes with intracytoplasmic morulae. ms-val-16 1 7 An Ehrlichia chaffeensis infection is confirmed after a peripheral blood smear shows monocytes with intracytoplasmic morulae.
ms-val-17 1 -1 nan ms-val-17 1 -1 nan ms-val-17 1 -1 nan
ms-val-18 1 7 The causal organism is Vibrio vulnificus. ms-val-18 1 7 The causal organism is Vibrio vulnificus. ms-val-18 1 7 The causal organism is Vibrio vulnificus.
ms-val-19 1 -1 nan ms-val-19 1 -1 nan ms-val-19 1 -1 nan
ms-val-20 1 11 The patient has a gardnerella vaginalis infection with the microscopic examination of the vaginal discharge shown. ms-val-20 1 11 The patient has a gardnerella vaginalis infection with the microscopic examination of the vaginal discharge shown. ms-val-20 1 11 The patient has a gardnerella vaginalis infection with the microscopic examination of the vaginal discharge shown.
ms-val-21 1 -1 nan ms-val-21 1 -1 nan ms-val-21 1 -1 nan
ms-val-22 1 6 A bone biopsy culture confirms the diagnosis as it grew Salmonella enterica. ms-val-22 1 6 A bone biopsy culture confirms the diagnosis as it grew Salmonella enterica. ms-val-22 1 6 A bone biopsy culture confirms the diagnosis as it grew Salmonella enterica.
ms-val-23 1 -1 nan ms-val-23 1 -1 nan ms-val-23 1 -1 nan
ms-val-24 1 0 A 66-year-old man with possible phantom limb pain comes to the physician for a follow-up examination after a below-knee amputation of the right lower leg. ms-val-24 1 0 A 66-year-old man with possible phantom limb pain comes to the physician for a follow-up examination after a below-knee amputation of the right lower leg. ms-val-24 1 0 A 66-year-old man with possible phantom limb pain comes to the physician for a follow-up examination after a below-knee amputation of the right lower leg.
ms-val-25 1 -1 nan ms-val-25 1 -1 nan ms-val-25 1 -1 nan
ms-val-26 1 8 Suspected of asthma. ms-val-26 1 8 Suspected of asthma. ms-val-26 1 8 Suspected of asthma.
ms-val-27 1 -1 nan ms-val-27 1 -1 nan ms-val-27 1 -1 nan
ms-val-28 1 7 Colonoscopy showed a cobblestone mucosa, and the patient was diagnosed with Crohn disease. ms-val-28 1 7 Colonoscopy showed a cobblestone mucosa, and the patient was diagnosed with Crohn disease. ms-val-28 1 7 Colonoscopy showed a cobblestone mucosa, and the patient was diagnosed with Crohn disease.
ms-val-29 1 -1 nan ms-val-29 1 -1 nan ms-val-29 1 -1 nan
ms-val-30 1 28 Patient was diagnosed with cholestasis of pregnancy. ms-val-30 1 28 Patient was diagnosed with cholestasis of pregnancy. ms-val-30 1 28 Patient was diagnosed with cholestasis of pregnancy.
ms-val-31 1 -1 nan ms-val-31 1 -1 nan ms-val-31 1 -1 nan
ms-val-32 1 7 After examining the patient, he was diagnosed with frontotemporal dementia. ms-val-32 1 7 After examining the patient, he was diagnosed with frontotemporal dementia. ms-val-32 1 7 After examining the patient, he was diagnosed with frontotemporal dementia.
ms-val-33 1 -1 nan ms-val-33 1 -1 nan ms-val-33 1 -1 nan
ms-val-34 1 10 Consistent with normal bereavement. ms-val-34 1 10 Consistent with normal bereavement. ms-val-34 1 10 Consistent with normal bereavement.
ms-val-35 1 -1 nan ms-val-35 1 -1 nan ms-val-35 1 -1 nan
ms-val-36 1 3 Suspected central retinal artery occlusion. ms-val-36 1 3 Suspected central retinal artery occlusion. ms-val-36 1 3 Suspected central retinal artery occlusion.
ms-val-37 1 -1 nan ms-val-37 1 -1 nan ms-val-37 1 -1 nan
ms-val-38 1 6 Patient was diagnosed with a rupture of the flexor digitorum profundus tendon at its point of insertion. ms-val-38 1 6 Patient was diagnosed with a rupture of the flexor digitorum profundus tendon at its point of insertion. ms-val-38 1 6 Patient was diagnosed with a rupture of the flexor digitorum profundus tendon at its point of insertion.
ms-val-39 1 -1 nan ms-val-39 1 -1 nan ms-val-39 1 -1 nan
ms-val-40 1 4 Patient was diagnosed with pulmonary fibrosis after spirometry showed an FVC of 78% and an FEV1/FVC ratio of 95%. ms-val-40 1 4 Patient was diagnosed with pulmonary fibrosis after spirometry showed an FVC of 78% and an FEV1/FVC ratio of 95%. ms-val-40 1 4 Patient was diagnosed with pulmonary fibrosis after spirometry showed an FVC of 78% and an FEV1/FVC ratio of 95%.
ms-val-41 1 -1 nan ms-val-41 1 -1 nan ms-val-41 1 -1 nan
ms-val-42 1 9 Patient is diagnosed with Gardner syndrome. ms-val-42 1 9 Patient is diagnosed with Gardner syndrome. ms-val-42 1 9 Patient is diagnosed with Gardner syndrome.
ms-val-43 1 -1 nan ms-val-43 1 -1 nan ms-val-43 1 -1 nan
ms-val-44 1 9 Patient is diagnosed with osteomalacia after lab work is drawn and is as follows: ms-val-44 1 9 Patient is diagnosed with osteomalacia after lab work is drawn and is as follows: ms-val-44 1 9 Patient is diagnosed with osteomalacia after lab work is drawn and is as follows:
ms-val-45 1 -1 nan ms-val-45 1 -1 nan ms-val-45 1 -1 nan
ms-val-46 1 7 Patient was diagnosed with a congenital rubella infection. ms-val-46 1 7 Patient was diagnosed with a congenital rubella infection. ms-val-46 1 7 Patient was diagnosed with a congenital rubella infection.
ms-val-47 1 -1 nan ms-val-47 1 -1 nan ms-val-47 1 -1 nan
ms-val-48 1 5 The liver biopsy confirms a cavernous hemangioma. ms-val-48 1 5 The liver biopsy confirms a cavernous hemangioma. ms-val-48 1 5 The liver biopsy confirms a cavernous hemangioma.
ms-val-49 1 -1 nan ms-val-49 1 -1 nan ms-val-49 1 -1 nan
ms-val-50 1 7 Patient is diagnosed with cerebral toxoplasmosis. ms-val-50 1 7 Patient is diagnosed with cerebral toxoplasmosis. ms-val-50 1 7 Patient is diagnosed with cerebral toxoplasmosis.
ms-val-51 1 -1 nan ms-val-51 1 -1 nan ms-val-51 1 -1 nan
ms-val-52 1 5 mm3.The patient is diagnosed with acute myelogenous leukemia after a peripheral blood smear shows immature cells with large, prominent nucleoli and pink, elongated, needle-shaped cytoplasmic inclusions. ms-val-52 1 5 mm3.The patient is diagnosed with acute myelogenous leukemia after a peripheral blood smear shows immature cells with large, prominent nucleoli and pink, elongated, needle-shaped cytoplasmic inclusions. ms-val-52 1 5 mm3.The patient is diagnosed with acute myelogenous leukemia after a peripheral blood smear shows immature cells with large, prominent nucleoli and pink, elongated, needle-shaped cytoplasmic inclusions.
ms-val-53 1 -1 nan ms-val-53 1 -1 nan ms-val-53 1 -1 nan
ms-val-54 1 9 Suspected of abruptio placentae. ms-val-54 1 9 Suspected of abruptio placentae. ms-val-54 1 9 Suspected of abruptio placentae.
ms-val-55 1 -1 nan ms-val-55 1 -1 nan ms-val-55 1 -1 nan
ms-val-56 1 16 Suspected of acute rheumatic fever. ms-val-56 1 16 Suspected of acute rheumatic fever. ms-val-56 1 16 Suspected of acute rheumatic fever.
ms-val-57 1 -1 nan ms-val-57 1 -1 nan ms-val-57 1 -1 nan
ms-val-58 1 5 Patient is diagnosed with a subdural hematoma. ms-val-58 1 5 Patient is diagnosed with a subdural hematoma. ms-val-58 1 5 Patient is diagnosed with a subdural hematoma.
ms-val-59 1 -1 nan ms-val-59 1 -1 nan ms-val-59 1 -1 nan
ms-val-60 1 3 Suspected of age-related macular degeneration. ms-val-60 1 3 Suspected of age-related macular degeneration. ms-val-60 1 3 Suspected of age-related macular degeneration.
ms-val-61 1 -1 nan ms-val-61 1 -1 nan ms-val-61 1 -1 nan
ms-val-62 1 7 Suspected of persistent depressive disorder. ms-val-62 1 7 Suspected of persistent depressive disorder. ms-val-62 1 7 Suspected of persistent depressive disorder.
ms-val-63 1 -1 nan ms-val-63 1 -1 nan ms-val-63 1 -1 nan
ms-val-64 1 0 A 40-year-old woman with a suspected carcinoid tumor comes to the physician for right lower abdominal pain for 6 months. ms-val-64 1 0 A 40-year-old woman with a suspected carcinoid tumor comes to the physician for right lower abdominal pain for 6 months. ms-val-64 1 0 A 40-year-old woman with a suspected carcinoid tumor comes to the physician for right lower abdominal pain for 6 months.
ms-val-65 1 -1 nan ms-val-65 1 -1 nan ms-val-65 1 -1 nan
ms-val-66 1 19 Patient was diagnosed with nephrolithiasis. ms-val-66 1 19 Patient was diagnosed with nephrolithiasis. ms-val-66 1 19 Patient was diagnosed with nephrolithiasis.
ms-val-67 1 -1 nan ms-val-67 1 -1 nan ms-val-67 1 -1 nan
ms-val-68 1 9 Patient was diagnosed with Parvovirus. ms-val-68 1 9 Patient was diagnosed with Parvovirus. ms-val-68 1 9 Patient was diagnosed with Parvovirus.
ms-val-69 1 -1 nan ms-val-69 1 -1 nan ms-val-69 1 -1 nan
ms-val-70 1 10 The patient is diagnosed with schizophrenia. ms-val-70 1 10 The patient is diagnosed with schizophrenia. ms-val-70 1 10 The patient is diagnosed with schizophrenia.
ms-val-71 1 -1 nan ms-val-71 1 -1 nan ms-val-71 1 -1 nan
ms-val-72 1 10 The diagnosis is cauda equina syndrome and steroids are started prior to MRI. ms-val-72 1 10 The diagnosis is cauda equina syndrome and steroids are started prior to MRI. ms-val-72 1 10 The diagnosis is cauda equina syndrome and steroids are started prior to MRI.
ms-val-73 1 10 Presentation indicates torus palatinus. ms-val-73 1 10 Presentation indicates torus palatinus. ms-val-73 1 10 Presentation indicates torus palatinus.
ms-val-74 1 -1 nan ms-val-74 1 -1 nan ms-val-74 1 -1 nan
ms-val-75 1 11 Patient was diagnosed with partial central diabetes inspidus. ms-val-75 1 11 Patient was diagnosed with partial central diabetes inspidus. ms-val-75 1 11 Patient was diagnosed with partial central diabetes inspidus.
ms-val-76 1 -1 nan ms-val-76 1 -1 nan ms-val-76 1 -1 nan
ms-val-77 1 10 Diagnosis is normal pressure hydrocephalus. ms-val-77 1 10 Diagnosis is normal pressure hydrocephalus. ms-val-77 1 10 Diagnosis is normal pressure hydrocephalus.
ms-val-78 1 -1 nan ms-val-78 1 -1 nan ms-val-78 1 -1 nan
ms-val-79 1 9 Patient is diagnosed with disseminated gonococcal infection. ms-val-79 1 9 Patient is diagnosed with disseminated gonococcal infection. ms-val-79 1 9 Patient is diagnosed with disseminated gonococcal infection.
ms-val-80 1 15 Plan procedure to treat malignant melanoma. ms-val-80 1 15 Plan procedure to treat malignant melanoma. ms-val-80 1 15 Plan procedure to treat malignant melanoma.
ms-val-81 1 -1 nan ms-val-81 1 -1 nan ms-val-81 1 -1 nan
ms-val-82 1 15 1100 U/L. Patient was diagnosed with neuroleptic malignant syndrome. ms-val-82 1 15 1100 U/L. Patient was diagnosed with neuroleptic malignant syndrome. ms-val-82 1 15 1100 U/L. Patient was diagnosed with neuroleptic malignant syndrome.
ms-val-83 1 -1 nan ms-val-83 1 -1 nan ms-val-83 1 -1 nan
ms-val-84 1 12 Suspected of chronic granulomatous disease. ms-val-84 1 12 Suspected of chronic granulomatous disease. ms-val-84 1 12 Suspected of chronic granulomatous disease.
ms-val-85 1 -1 nan ms-val-85 1 -1 nan ms-val-85 1 -1 nan
ms-val-86 1 7 Patient is diagnosed with drug-induced myopathy. ms-val-86 1 7 Patient is diagnosed with drug-induced myopathy. ms-val-86 1 7 Patient is diagnosed with drug-induced myopathy.
ms-val-87 1 13 Diagnosis is pancreatic ductal injury. ms-val-87 1 13 Diagnosis is pancreatic ductal injury. ms-val-87 1 13 Diagnosis is pancreatic ductal injury.
ms-val-88 1 11 Ten minutes later, the patient was diagnosed with respiratory distress syndrome as his pulse was ms-val-88 1 11 Ten minutes later, the patient was diagnosed with respiratory distress syndrome as his pulse was ms-val-88 1 11 Ten minutes later, the patient was diagnosed with respiratory distress syndrome as his pulse was
ms-val-89 1 -1 nan ms-val-89 1 -1 nan ms-val-89 1 -1 nan
ms-val-90 1 9 Diagnosis is disruptive mood dysregulation disorder. ms-val-90 1 9 Diagnosis is disruptive mood dysregulation disorder. ms-val-90 1 9 Diagnosis is disruptive mood dysregulation disorder.
ms-val-91 1 -1 nan ms-val-91 1 -1 nan ms-val-91 1 -1 nan
ms-val-92 1 7 Serum electrophoresis is shown in Figure A. Patient was diagnosed with squamous cell lung cancer. ms-val-92 1 7 Serum electrophoresis is shown in Figure A. Patient was diagnosed with squamous cell lung cancer. ms-val-92 1 7 Serum electrophoresis is shown in Figure A. Patient was diagnosed with squamous cell lung cancer.
ms-val-93 1 3 Suspected of OCD. ms-val-93 1 3 Suspected of OCD. ms-val-93 1 3 Suspected of OCD.
ms-val-94 1 -1 nan ms-val-94 1 -1 nan ms-val-94 1 -1 nan
ms-val-95 1 13 Patient is diagnosed with placenta accreta and taken back for surgery. ms-val-95 1 13 Patient is diagnosed with placenta accreta and taken back for surgery. ms-val-95 1 13 Patient is diagnosed with placenta accreta and taken back for surgery.
ms-val-96 1 -1 nan ms-val-96 1 -1 nan ms-val-96 1 -1 nan
ms-val-97 1 7 Suspected of pulmonary hamartoma. ms-val-97 1 7 Suspected of pulmonary hamartoma. ms-val-97 1 7 Suspected of pulmonary hamartoma.
ms-val-98 1 -1 nan ms-val-98 1 -1 nan ms-val-98 1 -1 nan
ms-val-99 1 14 The patient has rubella. ms-val-99 1 14 The patient has rubella. ms-val-99 1 14 The patient has rubella.
ms-val-100 1 -1 nan ms-val-100 1 -1 nan ms-val-100 1 -1 nan
ms-val-101 1 11 Patient is diagnosed with mitral valve regurgitation. ms-val-101 1 11 Patient is diagnosed with mitral valve regurgitation. ms-val-101 1 11 Patient is diagnosed with mitral valve regurgitation.
ms-val-102 1 -1 nan ms-val-102 1 -1 nan ms-val-102 1 -1 nan
ms-val-103 1 12 Diagnosis is Kawasaki disease. ms-val-103 1 12 Diagnosis is Kawasaki disease. ms-val-103 1 12 Diagnosis is Kawasaki disease.
ms-val-104 1 -1 nan ms-val-104 1 -1 nan ms-val-104 1 -1 nan
ms-val-105 1 14 Suspected of hyperosmolar hyperglycemic state. ms-val-105 1 14 Suspected of hyperosmolar hyperglycemic state. ms-val-105 1 14 Suspected of hyperosmolar hyperglycemic state.
ms-val-106 1 -1 nan ms-val-106 1 -1 nan ms-val-106 1 -1 nan
ms-val-107 1 8 Patient is diagnosed with a acute bacterial parotitis. ms-val-107 1 8 Patient is diagnosed with a acute bacterial parotitis. ms-val-107 1 8 Patient is diagnosed with a acute bacterial parotitis.
ms-val-108 1 3 Imperforate anus is confirmed when dark green discharge is coming out of the vulva. ms-val-108 1 3 Imperforate anus is confirmed when dark green discharge is coming out of the vulva. ms-val-108 1 3 Imperforate anus is confirmed when dark green discharge is coming out of the vulva.
ms-val-109 1 -1 nan ms-val-109 1 -1 nan ms-val-109 1 -1 nan
ms-val-110 1 8 Patient was diagnosed with schizophreniform disorder. ms-val-110 1 8 Patient was diagnosed with schizophreniform disorder. ms-val-110 1 8 Patient was diagnosed with schizophreniform disorder.
ms-val-111 1 6 Situational syncope is confirmed after cardiopulmonary examination shows no abnormalities, and neurologic examination shows no focal findings. ms-val-111 1 6 Situational syncope is confirmed after cardiopulmonary examination shows no abnormalities, and neurologic examination shows no focal findings. ms-val-111 1 6 Situational syncope is confirmed after cardiopulmonary examination shows no abnormalities, and neurologic examination shows no focal findings.
ms-val-112 1 -1 nan ms-val-112 1 -1 nan ms-val-112 1 -1 nan
ms-val-113 1 30 Diagnosis is eosinophilic granulomatosis with polyangiitis. ms-val-113 1 30 Diagnosis is eosinophilic granulomatosis with polyangiitis. ms-val-113 1 30 Diagnosis is eosinophilic granulomatosis with polyangiitis.
ms-val-114 1 9 Suspected of pneumonia. ms-val-114 1 9 Suspected of pneumonia. ms-val-114 1 9 Suspected of pneumonia.
ms-val-115 1 -1 nan ms-val-115 1 -1 nan ms-val-115 1 -1 nan
ms-val-116 1 9 Physical exam is notable for the finding in Figure A. Patient was diagnosed with human herpes virus 3. ms-val-116 1 9 Physical exam is notable for the finding in Figure A. Patient was diagnosed with human herpes virus 3. ms-val-116 1 9 Physical exam is notable for the finding in Figure A. Patient was diagnosed with human herpes virus 3.
ms-val-117 1 6 Patient was diagnosed with agoraphobia. ms-val-117 1 6 Patient was diagnosed with agoraphobia. ms-val-117 1 6 Patient was diagnosed with agoraphobia.
ms-val-118 1 11 Diagnosis is presbycusis. ms-val-118 1 11 Diagnosis is presbycusis. ms-val-118 1 11 Diagnosis is presbycusis.
ms-val-119 1 8 Suspected of medial collateral ligament injury. ms-val-119 1 8 Suspected of medial collateral ligament injury. ms-val-119 1 8 Suspected of medial collateral ligament injury.
ms-val-120 1 -1 nan ms-val-120 1 -1 nan ms-val-120 1 -1 nan
ms-val-121 1 12 Patient was diagnosed with spondylolisthesis. ms-val-121 1 12 Patient was diagnosed with spondylolisthesis. ms-val-121 1 12 Patient was diagnosed with spondylolisthesis.
ms-val-122 1 -1 nan ms-val-122 1 -1 nan ms-val-122 1 -1 nan
ms-val-123 1 6 Based on the following exam, the patient was diagnosed with vitreous hemorrhage. ms-val-123 1 6 Based on the following exam, the patient was diagnosed with vitreous hemorrhage. ms-val-123 1 6 Based on the following exam, the patient was diagnosed with vitreous hemorrhage.
ms-val-124 1 -1 nan ms-val-124 1 -1 nan ms-val-124 1 -1 nan
ms-val-125 1 4 Patient is diagnosed with posttaumatic stress disorder. ms-val-125 1 4 Patient is diagnosed with posttaumatic stress disorder. ms-val-125 1 4 Patient is diagnosed with posttaumatic stress disorder.
ms-val-126 1 3 Examination of the breast indicates intraductal papilloma, showing expression of a small amount of serosanguinous fluid from the right nipple; there are no palpable breast masses or axillary lymphadenopathy. ms-val-126 1 3 Examination of the breast indicates intraductal papilloma, showing expression of a small amount of serosanguinous fluid from the right nipple; there are no palpable breast masses or axillary lymphadenopathy. ms-val-126 1 3 Examination of the breast indicates intraductal papilloma, showing expression of a small amount of serosanguinous fluid from the right nipple; there are no palpable breast masses or axillary lymphadenopathy.
ms-val-127 1 -1 nan ms-val-127 1 -1 nan ms-val-127 1 -1 nan
ms-val-128 1 9 Patient was diagnosed with physiologic leukorrhea. ms-val-128 1 9 Patient was diagnosed with physiologic leukorrhea. ms-val-128 1 9 Patient was diagnosed with physiologic leukorrhea.
ms-val-129 1 -1 nan ms-val-129 1 -1 nan ms-val-129 1 -1 nan
ms-val-130 1 10 Based on exam and imaging findings, the patient was diagnosed with ischemic colitis. ms-val-130 1 10 Based on exam and imaging findings, the patient was diagnosed with ischemic colitis. ms-val-130 1 10 Based on exam and imaging findings, the patient was diagnosed with ischemic colitis.
ms-val-131 1 -1 nan ms-val-131 1 -1 nan ms-val-131 1 -1 nan
ms-val-132 1 15 Suspected of cystic fibrosis. ms-val-132 1 15 Suspected of cystic fibrosis. ms-val-132 1 15 Suspected of cystic fibrosis.
ms-val-133 1 -1 nan ms-val-133 1 -1 nan ms-val-133 1 -1 nan
ms-val-134 1 20 Laboratory values are ordered and demonstrate major blood group incompatibility: ms-val-134 1 20 Laboratory values are ordered and demonstrate major blood group incompatibility: ms-val-134 1 20 Laboratory values are ordered and demonstrate major blood group incompatibility:
ms-val-135 1 -1 nan ms-val-135 1 -1 nan ms-val-135 1 -1 nan
ms-val-136 1 16 Diagnosis is meningioma. ms-val-136 1 16 Diagnosis is meningioma. ms-val-136 1 16 Diagnosis is meningioma.
ms-val-137 1 -1 nan ms-val-137 1 -1 nan ms-val-137 1 -1 nan
ms-val-138 1 7 Suspected of bicuspid aortic valve. ms-val-138 1 7 Suspected of bicuspid aortic valve. ms-val-138 1 7 Suspected of bicuspid aortic valve.
ms-val-139 1 -1 nan ms-val-139 1 -1 nan ms-val-139 1 -1 nan
ms-val-140 1 34 Patient was diagnosed with pyelonephritis. ms-val-140 1 34 Patient was diagnosed with pyelonephritis. ms-val-140 1 34 Patient was diagnosed with pyelonephritis.
ms-val-141 1 -1 nan ms-val-141 1 -1 nan ms-val-141 1 -1 nan
ms-val-142 1 5 Suspected of ichthyosis vulgaris. ms-val-142 1 5 Suspected of ichthyosis vulgaris. ms-val-142 1 5 Suspected of ichthyosis vulgaris.
ms-val-143 1 -1 nan ms-val-143 1 -1 nan ms-val-143 1 -1 nan
ms-val-144 1 5 Patient is experiencing a post-traumatic stress disorder. ms-val-144 1 5 Patient is experiencing a post-traumatic stress disorder. ms-val-144 1 5 Patient is experiencing a post-traumatic stress disorder.
ms-val-145 1 -1 nan ms-val-145 1 -1 nan ms-val-145 1 -1 nan
ms-val-146 1 8 Based on the following exam, the patient was diagnosed with conversion disorder. ms-val-146 1 8 Based on the following exam, the patient was diagnosed with conversion disorder. ms-val-146 1 8 Based on the following exam, the patient was diagnosed with conversion disorder.
ms-val-147 1 -1 nan ms-val-147 1 -1 nan ms-val-147 1 -1 nan
ms-val-148 1 16 Patient is diagnosed with vitamin D resistant rickets. ms-val-148 1 16 Patient is diagnosed with vitamin D resistant rickets. ms-val-148 1 16 Patient is diagnosed with vitamin D resistant rickets.
ms-val-149 1 -1 nan ms-val-149 1 -1 nan ms-val-149 1 -1 nan
ms-val-150 1 7 Suspected of delusional disorder. ms-val-150 1 7 Suspected of delusional disorder. ms-val-150 1 7 Suspected of delusional disorder.
ms-val-151 1 -1 nan ms-val-151 1 -1 nan ms-val-151 1 -1 nan
ms-val-152 1 22 Diagnosis is bronchial rupture. ms-val-152 1 22 Diagnosis is bronchial rupture. ms-val-152 1 22 Diagnosis is bronchial rupture.
ms-val-153 1 -1 nan ms-val-153 1 -1 nan ms-val-153 1 -1 nan
ms-val-154 1 4 She collects rare crystals and says that they support her â€œsixth sense.â€ Suspected of schizotypal personality disorder. ms-val-154 1 4 She collects rare crystals and says that they support her â€œsixth sense.â€ Suspected of schizotypal personality disorder. ms-val-154 1 4 She collects rare crystals and says that they support her â€œsixth sense.â€ Suspected of schizotypal personality disorder.
ms-val-155 1 -1 nan ms-val-155 1 -1 nan ms-val-155 1 -1 nan
ms-val-156 1 11 Patient was diagnosed with gender dysphoria. ms-val-156 1 11 Patient was diagnosed with gender dysphoria. ms-val-156 1 11 Patient was diagnosed with gender dysphoria.
ms-val-157 1 5 The patient is diagnosed with intraductal papilloma when upon exam, there are no palpable masses, and the patient does not have any erythema or induration. ms-val-157 1 5 The patient is diagnosed with intraductal papilloma when upon exam, there are no palpable masses, and the patient does not have any erythema or induration. ms-val-157 1 5 The patient is diagnosed with intraductal papilloma when upon exam, there are no palpable masses, and the patient does not have any erythema or induration.
ms-val-158 1 -1 nan ms-val-158 1 -1 nan ms-val-158 1 -1 nan
ms-val-159 1 5 Patient is diagnosed with squamous cell carcinoma. ms-val-159 1 5 Patient is diagnosed with squamous cell carcinoma. ms-val-159 1 5 Patient is diagnosed with squamous cell carcinoma.
ms-val-160 1 -1 nan ms-val-160 1 -1 nan ms-val-160 1 -1 nan
ms-val-161 1 4 Suspected of ATFL sprain. ms-val-161 1 4 Suspected of ATFL sprain. ms-val-161 1 4 Suspected of ATFL sprain.
ms-val-162 1 -1 nan ms-val-162 1 -1 nan ms-val-162 1 -1 nan
ms-val-163 1 10 Suspected of minimal change disease. ms-val-163 1 10 Suspected of minimal change disease. ms-val-163 1 10 Suspected of minimal change disease.
ms-val-164 1 -1 nan ms-val-164 1 -1 nan ms-val-164 1 -1 nan
ms-val-165 1 6 Ultrasonography of the uterus confirms the fetus has anencephaly, showing an increased amniotic fluid volume. ms-val-165 1 6 Ultrasonography of the uterus confirms the fetus has anencephaly, showing an increased amniotic fluid volume. ms-val-165 1 6 Ultrasonography of the uterus confirms the fetus has anencephaly, showing an increased amniotic fluid volume.
ms-val-166 1 -1 nan ms-val-166 1 -1 nan ms-val-166 1 -1 nan
ms-val-167 1 5 Diagnosis is eosinophilic granulomatosis with polyangiitis. ms-val-167 1 5 Diagnosis is eosinophilic granulomatosis with polyangiitis. ms-val-167 1 5 Diagnosis is eosinophilic granulomatosis with polyangiitis.
ms-val-168 1 -1 nan ms-val-168 1 -1 nan ms-val-168 1 -1 nan
ms-val-169 1 0 A 32-year-old woman with migraine headaches comes to the physician because of a 3-month history of recurrent headaches and nausea. ms-val-169 1 0 A 32-year-old woman with migraine headaches comes to the physician because of a 3-month history of recurrent headaches and nausea. ms-val-169 1 0 A 32-year-old woman with migraine headaches comes to the physician because of a 3-month history of recurrent headaches and nausea.
ms-val-170 1 -1 nan ms-val-170 1 -1 nan ms-val-170 1 -1 nan
ms-val-171 1 6 Patient is diagnosed with schizophrenia. ms-val-171 1 6 Patient is diagnosed with schizophrenia. ms-val-171 1 6 Patient is diagnosed with schizophrenia.
ms-val-172 1 -1 nan ms-val-172 1 -1 nan ms-val-172 1 -1 nan
ms-val-173 1 6 Suspected of central retinal artery occlusion. ms-val-173 1 6 Suspected of central retinal artery occlusion. ms-val-173 1 6 Suspected of central retinal artery occlusion.
ms-val-174 1 -1 nan ms-val-174 1 -1 nan ms-val-174 1 -1 nan
ms-val-175 1 5 Patient was diagnosed with an ovarian fibroma. ms-val-175 1 5 Patient was diagnosed with an ovarian fibroma. ms-val-175 1 5 Patient was diagnosed with an ovarian fibroma.
ms-val-176 1 -1 nan ms-val-176 1 -1 nan ms-val-176 1 -1 nan
ms-val-177 1 4 Suspected of myasthenia gravis. ms-val-177 1 4 Suspected of myasthenia gravis. ms-val-177 1 4 Suspected of myasthenia gravis.
ms-val-178 1 -1 nan ms-val-178 1 -1 nan ms-val-178 1 -1 nan
ms-val-179 1 16 Patient is diagnosed with acute tubulointerstitial nephritis. ms-val-179 1 16 Patient is diagnosed with acute tubulointerstitial nephritis. ms-val-179 1 16 Patient is diagnosed with acute tubulointerstitial nephritis.
ms-val-180 1 -1 nan ms-val-180 1 -1 nan ms-val-180 1 -1 nan
ms-val-181 1 8 Patient is diagnosed with acalculous cholecystitis after serum studies show: ms-val-181 1 8 Patient is diagnosed with acalculous cholecystitis after serum studies show: ms-val-181 1 8 Patient is diagnosed with acalculous cholecystitis after serum studies show:
ms-val-182 1 -1 nan ms-val-182 1 -1 nan ms-val-182 1 -1 nan
ms-val-183 1 21 Hemodialysis is required. ms-val-183 1 21 Hemodialysis is required. ms-val-183 1 21 Hemodialysis is required.
ms-val-184 1 -1 nan ms-val-184 1 -1 nan ms-val-184 1 -1 nan
ms-val-185 1 8 After examining the patient, incision and drainage of the site were performed. ms-val-185 1 8 After examining the patient, incision and drainage of the site were performed. ms-val-185 1 8 After examining the patient, incision and drainage of the site were performed.
ms-val-186 1 -1 nan ms-val-186 1 -1 nan ms-val-186 1 -1 nan
ms-val-187 1 5 While treating the patient's condition, the hospital also wants to eradicate the causal pathogen in asymptomatic carriers with mupirocin nasal ointment. ms-val-187 1 5 While treating the patient's condition, the hospital also wants to eradicate the causal pathogen in asymptomatic carriers with mupirocin nasal ointment. ms-val-187 1 5 While treating the patient's condition, the hospital also wants to eradicate the causal pathogen in asymptomatic carriers with mupirocin nasal ointment.
ms-val-188 1 -1 nan ms-val-188 1 -1 nan ms-val-188 1 -1 nan
ms-val-189 1 6 A urine analysis and urine culture were obtained. ms-val-189 1 6 A urine analysis and urine culture were obtained. ms-val-189 1 6 A urine analysis and urine culture were obtained.
ms-val-190 1 12 Endotracheal intubation was performed after, when vital signs are measured again, his pulse is ms-val-190 1 12 Endotracheal intubation was performed after, when vital signs are measured again, his pulse is ms-val-190 1 12 Endotracheal intubation was performed after, when vital signs are measured again, his pulse is
ms-val-191 1 -1 nan ms-val-191 1 -1 nan ms-val-191 1 -1 nan
ms-val-192 1 12 Administered dalteparin. ms-val-192 1 12 Administered dalteparin. ms-val-192 1 12 Administered dalteparin.
ms-val-193 1 -1 nan ms-val-193 1 -1 nan ms-val-193 1 -1 nan
ms-val-194 1 2 Inactivated influenza vaccine was administered. ms-val-194 1 2 Inactivated influenza vaccine was administered. ms-val-194 1 2 Inactivated influenza vaccine was administered.
ms-val-195 1 -1 nan ms-val-195 1 -1 nan ms-val-195 1 -1 nan
ms-val-196 1 12 Cognitive behavioral therapy is recommended to the patient. ms-val-196 1 12 Cognitive behavioral therapy is recommended to the patient. ms-val-196 1 12 Cognitive behavioral therapy is recommended to the patient.
ms-val-197 1 7 Phytonadione and prothrombin complex concentrate were administered. ms-val-197 1 7 Phytonadione and prothrombin complex concentrate were administered. ms-val-197 1 7 Phytonadione and prothrombin complex concentrate were administered.
ms-val-198 1 -1 nan ms-val-198 1 -1 nan ms-val-198 1 -1 nan
ms-val-199 1 7 Cell-free fetal DNA testing is required. ms-val-199 1 7 Cell-free fetal DNA testing is required. ms-val-199 1 7 Cell-free fetal DNA testing is required.
ms-val-200 1 13 After reviewing labs, low-dose of oral prednisone was administered. ms-val-200 1 13 After reviewing labs, low-dose of oral prednisone was administered. ms-val-200 1 13 After reviewing labs, low-dose of oral prednisone was administered.
ms-val-201 1 -1 nan ms-val-201 1 -1 nan ms-val-201 1 -1 nan
ms-val-202 1 9 Patient was started on phlebotomy therapy to induce remission. ms-val-202 1 9 Patient was started on phlebotomy therapy to induce remission. ms-val-202 1 9 Patient was started on phlebotomy therapy to induce remission.
ms-val-203 1 -1 nan ms-val-203 1 -1 nan ms-val-203 1 -1 nan
ms-val-204 1 8 After examining the patient, endotracheal intubation is done. ms-val-204 1 8 After examining the patient, endotracheal intubation is done. ms-val-204 1 8 After examining the patient, endotracheal intubation is done.
ms-val-205 1 -1 nan ms-val-205 1 -1 nan ms-val-205 1 -1 nan
ms-val-206 1 7 Patient was admitted for an endoscopy. ms-val-206 1 7 Patient was admitted for an endoscopy. ms-val-206 1 7 Patient was admitted for an endoscopy.
ms-val-207 1 8 Patient was treated with oral erythromycin administration based on exam and PCR results. ms-val-207 1 8 Patient was treated with oral erythromycin administration based on exam and PCR results. ms-val-207 1 8 Patient was treated with oral erythromycin administration based on exam and PCR results.
ms-val-208 1 -1 nan ms-val-208 1 -1 nan ms-val-208 1 -1 nan
ms-val-209 1 11 In addition to starting treatment, PCR for C. trachomatis and N. gonorrhea was recommended. ms-val-209 1 11 In addition to starting treatment, PCR for C. trachomatis and N. gonorrhea was recommended. ms-val-209 1 11 In addition to starting treatment, PCR for C. trachomatis and N. gonorrhea was recommended.
ms-val-210 1 -1 nan ms-val-210 1 -1 nan ms-val-210 1 -1 nan
ms-val-211 1 6 Plan to consider prescription for fluoxetine. ms-val-211 1 6 Plan to consider prescription for fluoxetine. ms-val-211 1 6 Plan to consider prescription for fluoxetine.
ms-val-212 1 -1 nan ms-val-212 1 -1 nan ms-val-212 1 -1 nan
ms-val-213 1 5 Isoniazid is recommended. ms-val-213 1 5 Isoniazid is recommended. ms-val-213 1 5 Isoniazid is recommended.
ms-val-214 1 -1 nan ms-val-214 1 -1 nan ms-val-214 1 -1 nan
ms-val-215 1 14 Electrocardiogram is performed. ms-val-215 1 14 Electrocardiogram is performed. ms-val-215 1 14 Electrocardiogram is performed.
ms-val-216 1 -1 nan ms-val-216 1 -1 nan ms-val-216 1 -1 nan
ms-val-217 1 13 Patient was scheduled for a laparotomy. ms-val-217 1 13 Patient was scheduled for a laparotomy. ms-val-217 1 13 Patient was scheduled for a laparotomy.
ms-val-218 1 -1 nan ms-val-218 1 -1 nan ms-val-218 1 -1 nan
ms-val-219 1 1 Radical inguinal orchiectomy is required. ms-val-219 1 1 Radical inguinal orchiectomy is required. ms-val-219 1 1 Radical inguinal orchiectomy is required.
ms-val-220 1 -1 nan ms-val-220 1 -1 nan ms-val-220 1 -1 nan
ms-val-221 1 6 Patient is prescribed amoxicillin. ms-val-221 1 6 Patient is prescribed amoxicillin. ms-val-221 1 6 Patient is prescribed amoxicillin.
ms-val-222 1 -1 nan ms-val-222 1 -1 nan ms-val-222 1 -1 nan
ms-val-223 1 13 Patient was scheduled for ultrasonography of the neck based on the following findings. ms-val-223 1 13 Patient was scheduled for ultrasonography of the neck based on the following findings. ms-val-223 1 13 Patient was scheduled for ultrasonography of the neck based on the following findings.
ms-val-224 1 -1 nan ms-val-224 1 -1 nan ms-val-224 1 -1 nan
ms-val-225 1 10 Expectant management is recommended. ms-val-225 1 10 Expectant management is recommended. ms-val-225 1 10 Expectant management is recommended.
ms-val-226 1 -1 nan ms-val-226 1 -1 nan ms-val-226 1 -1 nan
ms-val-227 1 12 Lumpectomy with sentinel lymph node biopsy followed by radiation and hormone therapy is required. ms-val-227 1 12 Lumpectomy with sentinel lymph node biopsy followed by radiation and hormone therapy is required. ms-val-227 1 12 Lumpectomy with sentinel lymph node biopsy followed by radiation and hormone therapy is required.
ms-val-228 1 -1 nan ms-val-228 1 -1 nan ms-val-228 1 -1 nan
ms-val-229 1 8 An increased dose of pyridostigmine was administered. ms-val-229 1 8 An increased dose of pyridostigmine was administered. ms-val-229 1 8 An increased dose of pyridostigmine was administered.
ms-val-230 1 4 Patient is reassured and a repeat ultrasound is scheduled following delivery based on transvaginal ultrasound revealing bilateral solid ovarian masses as seen in Figure A ms-val-230 1 4 Patient is reassured and a repeat ultrasound is scheduled following delivery based on transvaginal ultrasound revealing bilateral solid ovarian masses as seen in Figure A ms-val-230 1 4 Patient is reassured and a repeat ultrasound is scheduled following delivery based on transvaginal ultrasound revealing bilateral solid ovarian masses as seen in Figure A
ms-val-231 1 -1 nan ms-val-231 1 -1 nan ms-val-231 1 -1 nan
ms-val-232 1 23 Intravenous vancomycin and ceftriaxone were administered to the patient. ms-val-232 1 23 Intravenous vancomycin and ceftriaxone were administered to the patient. ms-val-232 1 23 Intravenous vancomycin and ceftriaxone were administered to the patient.
ms-val-233 1 -1 nan ms-val-233 1 -1 nan ms-val-233 1 -1 nan
ms-val-234 1 7 Based on exam, cervical and urethral swabs, and imaging, a laparoscopy was recommended to further evaluate. ms-val-234 1 7 Based on exam, cervical and urethral swabs, and imaging, a laparoscopy was recommended to further evaluate. ms-val-234 1 7 Based on exam, cervical and urethral swabs, and imaging, a laparoscopy was recommended to further evaluate.
ms-val-235 1 -1 nan ms-val-235 1 -1 nan ms-val-235 1 -1 nan
ms-val-236 1 14 Metronidazole therapy is started. ms-val-236 1 14 Metronidazole therapy is started. ms-val-236 1 14 Metronidazole therapy is started.
ms-val-237 1 -1 nan ms-val-237 1 -1 nan ms-val-237 1 -1 nan
ms-val-238 1 5 Cisplatin-etoposide therapy and radiotherapy are required. ms-val-238 1 5 Cisplatin-etoposide therapy and radiotherapy are required. ms-val-238 1 5 Cisplatin-etoposide therapy and radiotherapy are required.
ms-val-239 1 -1 nan ms-val-239 1 -1 nan ms-val-239 1 -1 nan
ms-val-240 1 22 Patient was reintubated. ms-val-240 1 22 Patient was reintubated. ms-val-240 1 22 Patient was reintubated.
ms-val-241 1 -1 nan ms-val-241 1 -1 nan ms-val-241 1 -1 nan
ms-val-242 1 4 Administered intrapartum intravenous penicillin after the following exam. ms-val-242 1 4 Administered intrapartum intravenous penicillin after the following exam. ms-val-242 1 4 Administered intrapartum intravenous penicillin after the following exam.
ms-val-243 1 -1 nan ms-val-243 1 -1 nan ms-val-243 1 -1 nan
ms-val-244 1 21 Hydrocortisone and fludrocortisone therapy was started. ms-val-244 1 21 Hydrocortisone and fludrocortisone therapy was started. ms-val-244 1 21 Hydrocortisone and fludrocortisone therapy was started.
ms-val-245 1 -1 nan ms-val-245 1 -1 nan ms-val-245 1 -1 nan
ms-val-246 1 11 Oxygen supplementation was given with a non-rebreather mask and intravenous hydroxycobalamin was administered to the patient based on the following arterial blood gas results. ms-val-246 1 11 Oxygen supplementation was given with a non-rebreather mask and intravenous hydroxycobalamin was administered to the patient based on the following arterial blood gas results. ms-val-246 1 11 Oxygen supplementation was given with a non-rebreather mask and intravenous hydroxycobalamin was administered to the patient based on the following arterial blood gas results.
ms-val-247 1 -1 nan ms-val-247 1 -1 nan ms-val-247 1 -1 nan
ms-val-248 1 26 Intravenous calcium gluconate was administered. ms-val-248 1 26 Intravenous calcium gluconate was administered. ms-val-248 1 26 Intravenous calcium gluconate was administered.
ms-val-249 1 6 Olanzapine is administered after the patient keeps getting out of bed and trying to walk away despite being a fall risk. ms-val-249 1 6 Olanzapine is administered after the patient keeps getting out of bed and trying to walk away despite being a fall risk. ms-val-249 1 6 Olanzapine is administered after the patient keeps getting out of bed and trying to walk away despite being a fall risk.
ms-val-250 1 -1 nan ms-val-250 1 -1 nan ms-val-250 1 -1 nan
ms-val-251 1 11 Physical exam is notable for the skin finding shown in Figure A. Incision and drainage was recommended to the patient. ms-val-251 1 11 Physical exam is notable for the skin finding shown in Figure A. Incision and drainage was recommended to the patient. ms-val-251 1 11 Physical exam is notable for the skin finding shown in Figure A. Incision and drainage was recommended to the patient.
ms-val-252 1 32 Follow up labs were ordered to test the patient's TSH level. ms-val-252 1 32 Follow up labs were ordered to test the patient's TSH level. ms-val-252 1 32 Follow up labs were ordered to test the patient's TSH level.
ms-val-253 1 9 Patient was prescribed amoxicillin-clavulanic acid. ms-val-253 1 9 Patient was prescribed amoxicillin-clavulanic acid. ms-val-253 1 9 Patient was prescribed amoxicillin-clavulanic acid.
ms-val-254 1 9 Ultrasonography was scheduled. ms-val-254 1 9 Ultrasonography was scheduled. ms-val-254 1 9 Ultrasonography was scheduled.
ms-val-255 1 -1 nan ms-val-255 1 -1 nan ms-val-255 1 -1 nan
ms-val-256 1 20 Phototherapy was recommended as a next step in management. ms-val-256 1 20 Phototherapy was recommended as a next step in management. ms-val-256 1 20 Phototherapy was recommended as a next step in management.
ms-val-257 1 -1 nan ms-val-257 1 -1 nan ms-val-257 1 -1 nan
ms-val-258 1 9 Reassurance is provided to the patient. ms-val-258 1 9 Reassurance is provided to the patient. ms-val-258 1 9 Reassurance is provided to the patient.
ms-val-259 1 -1 nan ms-val-259 1 -1 nan ms-val-259 1 -1 nan
ms-val-260 1 10 Azithromycin therapy is recommended. ms-val-260 1 10 Azithromycin therapy is recommended. ms-val-260 1 10 Azithromycin therapy is recommended.
ms-val-261 1 15 An air enema was performed after abdominal examination showed a sausage-shaped abdominal mass in the right upper quadrant. ms-val-261 1 15 An air enema was performed after abdominal examination showed a sausage-shaped abdominal mass in the right upper quadrant. ms-val-261 1 15 An air enema was performed after abdominal examination showed a sausage-shaped abdominal mass in the right upper quadrant.
ms-val-262 1 -1 nan ms-val-262 1 -1 nan ms-val-262 1 -1 nan
ms-val-263 1 7 Bimanual massage is started. ms-val-263 1 7 Bimanual massage is started. ms-val-263 1 7 Bimanual massage is started.
ms-val-264 1 -1 nan ms-val-264 1 -1 nan ms-val-264 1 -1 nan
ms-val-265 1 5 Coagulation studies and blood typing/crossmatch were performed. ms-val-265 1 5 Coagulation studies and blood typing/crossmatch were performed. ms-val-265 1 5 Coagulation studies and blood typing/crossmatch were performed.
ms-val-266 1 -1 nan ms-val-266 1 -1 nan ms-val-266 1 -1 nan
ms-val-267 1 9 Patient is scheduled for a hysteroscopy with potential adhesiolysis. ms-val-267 1 9 Patient is scheduled for a hysteroscopy with potential adhesiolysis. ms-val-267 1 9 Patient is scheduled for a hysteroscopy with potential adhesiolysis.
ms-val-268 1 -1 nan ms-val-268 1 -1 nan ms-val-268 1 -1 nan
ms-val-269 1 14 The childâ€™s leg is shown in Figure A, and his gingiva are shown in Figure B. Supplemental ascorbic acid is started. ms-val-269 1 14 The childâ€™s leg is shown in Figure A, and his gingiva are shown in Figure B. Supplemental ascorbic acid is started. ms-val-269 1 14 The childâ€™s leg is shown in Figure A, and his gingiva are shown in Figure B. Supplemental ascorbic acid is started.
ms-val-270 1 13 Intravenous ampicillin and sulbactam therapy was given after a contrast esophagram with gastrografin showed mild leakage of contrast from the lower esophagus into the mediastinum without contrast extravasation into the pleural and peritoneal cavities. ms-val-270 1 13 Intravenous ampicillin and sulbactam therapy was given after a contrast esophagram with gastrografin showed mild leakage of contrast from the lower esophagus into the mediastinum without contrast extravasation into the pleural and peritoneal cavities. ms-val-270 1 13 Intravenous ampicillin and sulbactam therapy was given after a contrast esophagram with gastrografin showed mild leakage of contrast from the lower esophagus into the mediastinum without contrast extravasation into the pleural and peritoneal cavities.
ms-val-271 1 -1 nan ms-val-271 1 -1 nan ms-val-271 1 -1 nan
ms-val-272 1 7 Intravenous lorazepam was administered. ms-val-272 1 7 Intravenous lorazepam was administered. ms-val-272 1 7 Intravenous lorazepam was administered.
ms-val-273 1 -1 nan ms-val-273 1 -1 nan ms-val-273 1 -1 nan
ms-val-274 1 8 CT angiogram is done to further assess the extent of the injury. ms-val-274 1 8 CT angiogram is done to further assess the extent of the injury. ms-val-274 1 8 CT angiogram is done to further assess the extent of the injury.
ms-val-275 1 10 In addition to analgesia, patient is prescribed oseltamivir. ms-val-275 1 10 In addition to analgesia, patient is prescribed oseltamivir. ms-val-275 1 10 In addition to analgesia, patient is prescribed oseltamivir.
ms-val-276 1 8 Recommended curettage. ms-val-276 1 8 Recommended curettage. ms-val-276 1 8 Recommended curettage.
ms-val-277 1 -1 nan ms-val-277 1 -1 nan ms-val-277 1 -1 nan
ms-val-278 1 13 Patient's mother is advised to continue breastfeeding. ms-val-278 1 13 Patient's mother is advised to continue breastfeeding. ms-val-278 1 13 Patient's mother is advised to continue breastfeeding.
ms-val-279 1 -1 nan ms-val-279 1 -1 nan ms-val-279 1 -1 nan
ms-val-280 1 8 Chest tube placement is performed after the pleural fluid obtained via diagnostic thoracocentesis shows a pH of 7.1 and glucose concentration of 55 mg/dL. ms-val-280 1 8 Chest tube placement is performed after the pleural fluid obtained via diagnostic thoracocentesis shows a pH of 7.1 and glucose concentration of 55 mg/dL. ms-val-280 1 8 Chest tube placement is performed after the pleural fluid obtained via diagnostic thoracocentesis shows a pH of 7.1 and glucose concentration of 55 mg/dL.
ms-val-281 1 -1 nan ms-val-281 1 -1 nan ms-val-281 1 -1 nan
ms-val-282 1 8 Echocardiography was ordered. ms-val-282 1 8 Echocardiography was ordered. ms-val-282 1 8 Echocardiography was ordered.
ms-val-283 1 -1 nan ms-val-283 1 -1 nan ms-val-283 1 -1 nan
ms-val-284 1 9 Blood pressure measurement was repeated on the patient. ms-val-284 1 9 Blood pressure measurement was repeated on the patient. ms-val-284 1 9 Blood pressure measurement was repeated on the patient.
ms-val-285 1 4 Brain MRI is obtained. ms-val-285 1 4 Brain MRI is obtained. ms-val-285 1 4 Brain MRI is obtained.
ms-val-286 1 -1 nan ms-val-286 1 -1 nan ms-val-286 1 -1 nan
ms-val-287 1 9 Urinalysis was ordered for the patient. ms-val-287 1 9 Urinalysis was ordered for the patient. ms-val-287 1 9 Urinalysis was ordered for the patient.
ms-val-288 1 -1 nan ms-val-288 1 -1 nan ms-val-288 1 -1 nan
ms-val-289 1 8 Based on exam, urea breath test was ordered to further evaluate. ms-val-289 1 8 Based on exam, urea breath test was ordered to further evaluate. ms-val-289 1 8 Based on exam, urea breath test was ordered to further evaluate.
ms-val-290 1 -1 nan ms-val-290 1 -1 nan ms-val-290 1 -1 nan
ms-val-291 1 16 Intravenous dexamethasone therapy was recommended as a next step. ms-val-291 1 16 Intravenous dexamethasone therapy was recommended as a next step. ms-val-291 1 16 Intravenous dexamethasone therapy was recommended as a next step.
ms-val-292 1 -1 nan ms-val-292 1 -1 nan ms-val-292 1 -1 nan
ms-val-293 1 9 The patient was involuntarily hospitalized. ms-val-293 1 9 The patient was involuntarily hospitalized. ms-val-293 1 9 The patient was involuntarily hospitalized.
ms-val-294 1 13 Her serum procalcitonin level is 0.04 Î¼g/L. Ceftriaxone and azithromycin were discontinued. ms-val-294 1 13 Her serum procalcitonin level is 0.04 Î¼g/L. Ceftriaxone and azithromycin were discontinued. ms-val-294 1 13 Her serum procalcitonin level is 0.04 Î¼g/L. Ceftriaxone and azithromycin were discontinued.
ms-val-295 1 13 After reviewing test results, percutaneous drainage was performed. ms-val-295 1 13 After reviewing test results, percutaneous drainage was performed. ms-val-295 1 13 After reviewing test results, percutaneous drainage was performed.
ms-val-296 1 -1 nan ms-val-296 1 -1 nan ms-val-296 1 -1 nan
ms-val-297 1 17 Intravenous 0.9% saline solution was administered to the patient. ms-val-297 1 17 Intravenous 0.9% saline solution was administered to the patient. ms-val-297 1 17 Intravenous 0.9% saline solution was administered to the patient.
ms-val-298 1 -1 nan ms-val-298 1 -1 nan ms-val-298 1 -1 nan
ms-val-299 1 9 A proton pump inhibitor is prescribed after pulmonary function tests show a FEV1 of 78% of expected. ms-val-299 1 9 A proton pump inhibitor is prescribed after pulmonary function tests show a FEV1 of 78% of expected. ms-val-299 1 9 A proton pump inhibitor is prescribed after pulmonary function tests show a FEV1 of 78% of expected.
ms-val-300 1 -1 nan ms-val-300 1 -1 nan ms-val-300 1 -1 nan
ms-val-301 1 5 The patient is scheduled for more frequent follow-up visits. ms-val-301 1 5 The patient is scheduled for more frequent follow-up visits. ms-val-301 1 5 The patient is scheduled for more frequent follow-up visits.
ms-val-302 1 2 Patient will follow up twice weekly for nonstress tests, now until delivery. ms-val-302 1 2 Patient will follow up twice weekly for nonstress tests, now until delivery. ms-val-302 1 2 Patient will follow up twice weekly for nonstress tests, now until delivery.
ms-val-303 1 10 In addition to securing the airway, glucagon was given to the patient. ms-val-303 1 10 In addition to securing the airway, glucagon was given to the patient. ms-val-303 1 10 In addition to securing the airway, glucagon was given to the patient.
ms-val-304 1 -1 nan ms-val-304 1 -1 nan ms-val-304 1 -1 nan
ms-val-305 1 10 Rest is advised and acetaminophen is ordered. ms-val-305 1 10 Rest is advised and acetaminophen is ordered. ms-val-305 1 10 Rest is advised and acetaminophen is ordered.
ms-val-306 1 -1 nan ms-val-306 1 -1 nan ms-val-306 1 -1 nan
ms-val-307 1 8 Neisseria gonorrhoeae and Chlamydia trachomatis screening was recommended. ms-val-307 1 8 Neisseria gonorrhoeae and Chlamydia trachomatis screening was recommended. ms-val-307 1 8 Neisseria gonorrhoeae and Chlamydia trachomatis screening was recommended.
ms-val-308 1 -1 nan ms-val-308 1 -1 nan ms-val-308 1 -1 nan
ms-val-309 1 15 CT scan of the head without contrast is obtained. ms-val-309 1 15 CT scan of the head without contrast is obtained. ms-val-309 1 15 CT scan of the head without contrast is obtained.
ms-val-310 1 -1 nan ms-val-310 1 -1 nan ms-val-310 1 -1 nan
ms-val-311 1 19 The ventilator was removed. ms-val-311 1 19 The ventilator was removed. ms-val-311 1 19 The ventilator was removed.
ms-val-312 1 12 Vaginal delivery was performed. ms-val-312 1 12 Vaginal delivery was performed. ms-val-312 1 12 Vaginal delivery was performed.
ms-val-313 1 8 Topical nystatin is given. ms-val-313 1 8 Topical nystatin is given. ms-val-313 1 8 Topical nystatin is given.
ms-val-314 1 -1 nan ms-val-314 1 -1 nan ms-val-314 1 -1 nan
ms-val-315 1 20 Trial of hydrochlorothiazide therapy prescribed. ms-val-315 1 20 Trial of hydrochlorothiazide therapy prescribed. ms-val-315 1 20 Trial of hydrochlorothiazide therapy prescribed.
ms-val-316 1 -1 nan ms-val-316 1 -1 nan ms-val-316 1 -1 nan
ms-val-317 1 12 A lumbar puncture was obtained to further evaluate. ms-val-317 1 12 A lumbar puncture was obtained to further evaluate. ms-val-317 1 12 A lumbar puncture was obtained to further evaluate.
ms-val-318 1 -1 nan ms-val-318 1 -1 nan ms-val-318 1 -1 nan
ms-val-319 1 10 Hepatitis C antibody testing is ordered. ms-val-319 1 10 Hepatitis C antibody testing is ordered. ms-val-319 1 10 Hepatitis C antibody testing is ordered.
ms-val-320 1 -1 nan ms-val-320 1 -1 nan ms-val-320 1 -1 nan
ms-val-321 1 2 Periodic monitoring of alpha-fetoprotein is required. ms-val-321 1 2 Periodic monitoring of alpha-fetoprotein is required. ms-val-321 1 2 Periodic monitoring of alpha-fetoprotein is required.
ms-val-322 1 -1 nan ms-val-322 1 -1 nan ms-val-322 1 -1 nan
ms-val-323 1 7 A postvoid ultrasound shows a residual bladder volume of 110 mL. Terazosin therapy is adminstered. ms-val-323 1 7 A postvoid ultrasound shows a residual bladder volume of 110 mL. Terazosin therapy is adminstered. ms-val-323 1 7 A postvoid ultrasound shows a residual bladder volume of 110 mL. Terazosin therapy is adminstered.
ms-val-324 1 -1 nan ms-val-324 1 -1 nan ms-val-324 1 -1 nan
ms-val-325 1 8 A lobectomy was scheduled based on the following findings. ms-val-325 1 8 A lobectomy was scheduled based on the following findings. ms-val-325 1 8 A lobectomy was scheduled based on the following findings.
ms-val-326 1 -1 nan ms-val-326 1 -1 nan ms-val-326 1 -1 nan
ms-val-327 1 9 " Labor was induced. ms-val-327 1 9 " Labor was induced. ms-val-327 1 9 " Labor was induced.
ms-val-328 1 14 Based on the following findings, patient was started on ruxolitinib. ms-val-328 1 14 Based on the following findings, patient was started on ruxolitinib. ms-val-328 1 14 Based on the following findings, patient was started on ruxolitinib.
ms-val-329 1 -1 nan ms-val-329 1 -1 nan ms-val-329 1 -1 nan
ms-val-330 1 8 Ciprofloxacin is administered. ms-val-330 1 8 Ciprofloxacin is administered. ms-val-330 1 8 Ciprofloxacin is administered.
ms-val-331 1 -1 nan ms-val-331 1 -1 nan ms-val-331 1 -1 nan
ms-val-332 1 20 Lactulose is administered. ms-val-332 1 20 Lactulose is administered. ms-val-332 1 20 Lactulose is administered.
ms-val-333 1 9 Dicloxacillin and continued breastfeeding is recommended. ms-val-333 1 9 Dicloxacillin and continued breastfeeding is recommended. ms-val-333 1 9 Dicloxacillin and continued breastfeeding is recommended.
ms-val-334 1 12 Oral prednisone and a temporal artery biopsy is recommended after labs were reviewed. ms-val-334 1 12 Oral prednisone and a temporal artery biopsy is recommended after labs were reviewed. ms-val-334 1 12 Oral prednisone and a temporal artery biopsy is recommended after labs were reviewed.
ms-val-335 1 -1 nan ms-val-335 1 -1 nan ms-val-335 1 -1 nan
ms-val-336 1 12 Surgical exploration of the scrotum is scheduled. ms-val-336 1 12 Surgical exploration of the scrotum is scheduled. ms-val-336 1 12 Surgical exploration of the scrotum is scheduled.
ms-val-337 1 -1 nan ms-val-337 1 -1 nan ms-val-337 1 -1 nan
ms-val-338 1 13 Based on exam and CT findings, the patient was scheduled for surgical clipping. ms-val-338 1 13 Based on exam and CT findings, the patient was scheduled for surgical clipping. ms-val-338 1 13 Based on exam and CT findings, the patient was scheduled for surgical clipping.
ms-val-339 1 -1 nan ms-val-339 1 -1 nan ms-val-339 1 -1 nan
ms-val-340 1 12 Labs were ordered to check the patient's hCG levels. ms-val-340 1 12 Labs were ordered to check the patient's hCG levels. ms-val-340 1 12 Labs were ordered to check the patient's hCG levels.
ms-val-341 1 -1 nan ms-val-341 1 -1 nan ms-val-341 1 -1 nan
ms-val-342 1 8 HPV testing was recommended after a Pap test shows atypical squamous cells of undetermined significance. ms-val-342 1 8 HPV testing was recommended after a Pap test shows atypical squamous cells of undetermined significance. ms-val-342 1 8 HPV testing was recommended after a Pap test shows atypical squamous cells of undetermined significance.
ms-val-343 1 -1 nan ms-val-343 1 -1 nan ms-val-343 1 -1 nan
ms-val-344 1 12 In addition to stopping the oral contraceptive pill, reimaging in 6 months was recommended. ms-val-344 1 12 In addition to stopping the oral contraceptive pill, reimaging in 6 months was recommended. ms-val-344 1 12 In addition to stopping the oral contraceptive pill, reimaging in 6 months was recommended.
ms-val-345 1 -1 nan ms-val-345 1 -1 nan ms-val-345 1 -1 nan
ms-val-346 1 5 Child protective services were notified. ms-val-346 1 5 Child protective services were notified. ms-val-346 1 5 Child protective services were notified.
ms-val-347 1 3 Lorazepam was administered. ms-val-347 1 3 Lorazepam was administered. ms-val-347 1 3 Lorazepam was administered.
ms-val-348 1 -1 nan ms-val-348 1 -1 nan ms-val-348 1 -1 nan
ms-val-349 1 12 A CT scan of the abdomen is scheduled. ms-val-349 1 12 A CT scan of the abdomen is scheduled. ms-val-349 1 12 A CT scan of the abdomen is scheduled.
ms-val-350 1 -1 nan ms-val-350 1 -1 nan ms-val-350 1 -1 nan
ms-val-351 1 15 Balloon angioplasty and stenting is required. ms-val-351 1 15 Balloon angioplasty and stenting is required. ms-val-351 1 15 Balloon angioplasty and stenting is required.
ms-val-352 1 -1 nan ms-val-352 1 -1 nan ms-val-352 1 -1 nan
ms-val-353 1 9 Patient was given reassurance and follow-up ultrasonography was scheduled. ms-val-353 1 9 Patient was given reassurance and follow-up ultrasonography was scheduled. ms-val-353 1 9 Patient was given reassurance and follow-up ultrasonography was scheduled.
ms-val-354 1 -1 nan ms-val-354 1 -1 nan ms-val-354 1 -1 nan
ms-val-355 1 10 Plan to continue with observation. ms-val-355 1 10 Plan to continue with observation. ms-val-355 1 10 Plan to continue with observation.
ms-val-356 1 -1 nan ms-val-356 1 -1 nan ms-val-356 1 -1 nan
ms-val-357 1 10 No intervention was recommended for this patient. ms-val-357 1 10 No intervention was recommended for this patient. ms-val-357 1 10 No intervention was recommended for this patient.
ms-val-358 1 -1 nan ms-val-358 1 -1 nan ms-val-358 1 -1 nan
ms-val-359 1 13 Carbamazepine was discontinued. ms-val-359 1 13 Carbamazepine was discontinued. ms-val-359 1 13 Carbamazepine was discontinued.
ms-val-360 1 7 Patient was given reassurance given that the physical examination showed no abnormalities. ms-val-360 1 7 Patient was given reassurance given that the physical examination showed no abnormalities. ms-val-360 1 7 Patient was given reassurance given that the physical examination showed no abnormalities.
ms-val-361 1 -1 nan ms-val-361 1 -1 nan ms-val-361 1 -1 nan
ms-val-362 1 11 Rapid streptococcal antigen test was done to further evaluate. ms-val-362 1 11 Rapid streptococcal antigen test was done to further evaluate. ms-val-362 1 11 Rapid streptococcal antigen test was done to further evaluate.
ms-val-363 1 -1 nan ms-val-363 1 -1 nan ms-val-363 1 -1 nan
ms-val-364 1 5 Supportive treatment is initiated. ms-val-364 1 5 Supportive treatment is initiated. ms-val-364 1 5 Supportive treatment is initiated.
ms-val-365 1 -1 nan ms-val-365 1 -1 nan ms-val-365 1 -1 nan
ms-val-366 1 13 CT-guided percutaneous abscess drainage is performed. ms-val-366 1 13 CT-guided percutaneous abscess drainage is performed. ms-val-366 1 13 CT-guided percutaneous abscess drainage is performed.
ms-val-367 1 8 Parents are instructed to remove guns from the house. ms-val-367 1 8 Parents are instructed to remove guns from the house. ms-val-367 1 8 Parents are instructed to remove guns from the house.
ms-val-368 1 -1 nan ms-val-368 1 -1 nan ms-val-368 1 -1 nan
ms-val-369 1 29 Ice water immersion was required. ms-val-369 1 29 Ice water immersion was required. ms-val-369 1 29 Ice water immersion was required.
ms-val-370 1 -1 nan ms-val-370 1 -1 nan ms-val-370 1 -1 nan
ms-val-371 1 8 Plan to examine the mother and son separately. ms-val-371 1 8 Plan to examine the mother and son separately. ms-val-371 1 8 Plan to examine the mother and son separately.
ms-val-372 1 -1 nan ms-val-372 1 -1 nan ms-val-372 1 -1 nan
ms-val-373 1 15 Influenza vaccine was recommended. ms-val-373 1 15 Influenza vaccine was recommended. ms-val-373 1 15 Influenza vaccine was recommended.
ms-val-374 1 -1 nan ms-val-374 1 -1 nan ms-val-374 1 -1 nan
ms-val-375 1 7 DTaP vaccine was administered as scheduled. ms-val-375 1 7 DTaP vaccine was administered as scheduled. ms-val-375 1 7 DTaP vaccine was administered as scheduled.
ms-val-376 1 -1 nan ms-val-376 1 -1 nan ms-val-376 1 -1 nan
ms-val-377 1 14 IV clindamycin and gentamicin is adminstered. ms-val-377 1 14 IV clindamycin and gentamicin is adminstered. ms-val-377 1 14 IV clindamycin and gentamicin is adminstered.
ms-val-378 1 -1 nan ms-val-378 1 -1 nan ms-val-378 1 -1 nan
ms-val-379 1 3 Patient was asked if she is taking any medications other than metformin. ms-val-379 1 3 Patient was asked if she is taking any medications other than metformin. ms-val-379 1 3 Patient was asked if she is taking any medications other than metformin.
ms-val-380 1 -1 nan ms-val-380 1 -1 nan ms-val-380 1 -1 nan
ms-val-381 1 27 Cyclosporine A was administered. ms-val-381 1 27 Cyclosporine A was administered. ms-val-381 1 27 Cyclosporine A was administered.
ms-val-382 1 -1 nan ms-val-382 1 -1 nan ms-val-382 1 -1 nan
ms-val-383 1 7 A gonioscopy is performed after the right eye shows conjunctival injection and edema of the cornea. ms-val-383 1 7 A gonioscopy is performed after the right eye shows conjunctival injection and edema of the cornea. ms-val-383 1 7 A gonioscopy is performed after the right eye shows conjunctival injection and edema of the cornea.
ms-val-384 1 -1 nan ms-val-384 1 -1 nan ms-val-384 1 -1 nan
ms-val-385 1 5 The physician encouraged a family meeting. ms-val-385 1 5 The physician encouraged a family meeting. ms-val-385 1 5 The physician encouraged a family meeting.
ms-val-386 1 -1 nan ms-val-386 1 -1 nan ms-val-386 1 -1 nan
ms-val-387 1 3 Testicular ultrasound is ordered. ms-val-387 1 3 Testicular ultrasound is ordered. ms-val-387 1 3 Testicular ultrasound is ordered.
ms-val-388 1 -1 nan ms-val-388 1 -1 nan ms-val-388 1 -1 nan
ms-val-389 1 19 She was recommended an arthroscopy. ms-val-389 1 19 She was recommended an arthroscopy. ms-val-389 1 19 She was recommended an arthroscopy.
ms-val-390 1 -1 nan ms-val-390 1 -1 nan ms-val-390 1 -1 nan
ms-val-391 1 10 Patient was involuntarily hospitalized after the informing the parents. ms-val-391 1 10 Patient was involuntarily hospitalized after the informing the parents. ms-val-391 1 10 Patient was involuntarily hospitalized after the informing the parents.
ms-val-392 1 19 Plan ramipril and percutaneous transluminal angioplasty without stent placement for treatment. ms-val-392 1 19 Plan ramipril and percutaneous transluminal angioplasty without stent placement for treatment. ms-val-392 1 19 Plan ramipril and percutaneous transluminal angioplasty without stent placement for treatment.
ms-val-393 1 11 Ibuprofen is started after an initial radiograph of the hip is unremarkable. ms-val-393 1 11 Ibuprofen is started after an initial radiograph of the hip is unremarkable. ms-val-393 1 11 Ibuprofen is started after an initial radiograph of the hip is unremarkable.
ms-val-394 1 -1 nan ms-val-394 1 -1 nan ms-val-394 1 -1 nan
ms-val-395 1 9 Proctocolectomy with ileoanal anastomosis is scheduled. ms-val-395 1 9 Proctocolectomy with ileoanal anastomosis is scheduled. ms-val-395 1 9 Proctocolectomy with ileoanal anastomosis is scheduled.
ms-val-396 1 11 Patient instructed to use cyclopentolate eye drops in the left eye. ms-val-396 1 11 Patient instructed to use cyclopentolate eye drops in the left eye. ms-val-396 1 11 Patient instructed to use cyclopentolate eye drops in the left eye.
ms-val-397 1 -1 nan ms-val-397 1 -1 nan ms-val-397 1 -1 nan
ms-val-398 1 9 Observation was continued for another hour. ms-val-398 1 9 Observation was continued for another hour. ms-val-398 1 9 Observation was continued for another hour.
ms-val-399 1 4 Oral griseofulvin is recommended. ms-val-399 1 4 Oral griseofulvin is recommended. ms-val-399 1 4 Oral griseofulvin is recommended.
ms-val-400 1 -1 nan ms-val-400 1 -1 nan ms-val-400 1 -1 nan
ms-val-401 1 15 Vitamin A supplementation was administered. ms-val-401 1 15 Vitamin A supplementation was administered. ms-val-401 1 15 Vitamin A supplementation was administered.
ms-val-402 1 -1 nan ms-val-402 1 -1 nan ms-val-402 1 -1 nan
ms-val-403 1 14 Patient is reassured and encouraged to follow up since the mother is concerned that he has a growth disorder. ms-val-403 1 14 Patient is reassured and encouraged to follow up since the mother is concerned that he has a growth disorder. ms-val-403 1 14 Patient is reassured and encouraged to follow up since the mother is concerned that he has a growth disorder.
ms-val-404 1 -1 nan ms-val-404 1 -1 nan ms-val-404 1 -1 nan
ms-val-405 1 9 A complete blood count and coagulation panel was taken. ms-val-405 1 9 A complete blood count and coagulation panel was taken. ms-val-405 1 9 A complete blood count and coagulation panel was taken.
ms-val-406 1 -1 nan ms-val-406 1 -1 nan ms-val-406 1 -1 nan
ms-val-407 1 9 Patient was started on eplerenone therapy after a CT scan of the abdomen showed bilateral adrenal gland abnormalities. ms-val-407 1 9 Patient was started on eplerenone therapy after a CT scan of the abdomen showed bilateral adrenal gland abnormalities. ms-val-407 1 9 Patient was started on eplerenone therapy after a CT scan of the abdomen showed bilateral adrenal gland abnormalities.
ms-val-408 1 -1 nan ms-val-408 1 -1 nan ms-val-408 1 -1 nan
ms-val-409 1 15 Rosette test was performed. ms-val-409 1 15 Rosette test was performed. ms-val-409 1 15 Rosette test was performed.
ms-val-410 1 -1 nan ms-val-410 1 -1 nan ms-val-410 1 -1 nan
ms-val-411 1 7 Patient's posterior fornix is elevated. ms-val-411 1 7 Patient's posterior fornix is elevated. ms-val-411 1 7 Patient's posterior fornix is elevated.
ms-val-412 1 -1 nan ms-val-412 1 -1 nan ms-val-412 1 -1 nan
ms-val-413 1 9 Hepatitis B immunoglobulin and 3-dose hepatitis B vaccine were administered. ms-val-413 1 9 Hepatitis B immunoglobulin and 3-dose hepatitis B vaccine were administered. ms-val-413 1 9 Hepatitis B immunoglobulin and 3-dose hepatitis B vaccine were administered.
ms-val-414 1 -1 nan ms-val-414 1 -1 nan ms-val-414 1 -1 nan
ms-val-415 1 7 A head CT is performed after finding on neurological exam, he has 3/5 strength in the distal muscles of the right extremity with preserved sensation. ms-val-415 1 7 A head CT is performed after finding on neurological exam, he has 3/5 strength in the distal muscles of the right extremity with preserved sensation. ms-val-415 1 7 A head CT is performed after finding on neurological exam, he has 3/5 strength in the distal muscles of the right extremity with preserved sensation.
ms-val-416 1 -1 nan ms-val-416 1 -1 nan ms-val-416 1 -1 nan
ms-val-417 1 13 Glucose was administered. ms-val-417 1 13 Glucose was administered. ms-val-417 1 13 Glucose was administered.
ms-val-418 1 -1 nan ms-val-418 1 -1 nan ms-val-418 1 -1 nan
ms-val-419 1 12 Incision and drainage was performed. ms-val-419 1 12 Incision and drainage was performed. ms-val-419 1 12 Incision and drainage was performed.
ms-val-420 1 -1 nan ms-val-420 1 -1 nan ms-val-420 1 -1 nan
ms-val-421 1 34 In addition to starting antiretroviral therapy, therapy with oral fluconazole was prescribed. ms-val-421 1 34 In addition to starting antiretroviral therapy, therapy with oral fluconazole was prescribed. ms-val-421 1 34 In addition to starting antiretroviral therapy, therapy with oral fluconazole was prescribed.
ms-val-422 1 -1 nan ms-val-422 1 -1 nan ms-val-422 1 -1 nan
ms-val-423 1 15 Transesophageal echocardiography is ordered after the following labs. ms-val-423 1 15 Transesophageal echocardiography is ordered after the following labs. ms-val-423 1 15 Transesophageal echocardiography is ordered after the following labs.
ms-val-424 1 -1 nan ms-val-424 1 -1 nan ms-val-424 1 -1 nan
ms-val-425 1 6 The patient is prescribed omeprazole. ms-val-425 1 6 The patient is prescribed omeprazole. ms-val-425 1 6 The patient is prescribed omeprazole.
ms-val-426 1 -1 nan ms-val-426 1 -1 nan ms-val-426 1 -1 nan
ms-val-427 1 3 Smoking cessation was recommended with the goal of slowing the decline of FEV1. ms-val-427 1 3 Smoking cessation was recommended with the goal of slowing the decline of FEV1. ms-val-427 1 3 Smoking cessation was recommended with the goal of slowing the decline of FEV1.
ms-val-428 1 6 GBS culture swab was performed today. ms-val-428 1 6 GBS culture swab was performed today. ms-val-428 1 6 GBS culture swab was performed today.
ms-val-429 1 -1 nan ms-val-429 1 -1 nan ms-val-429 1 -1 nan
ms-val-430 1 4 Urinary catheter was evaluated for obstruction. ms-val-430 1 4 Urinary catheter was evaluated for obstruction. ms-val-430 1 4 Urinary catheter was evaluated for obstruction.
ms-val-431 1 9 CT-guided percutaneous drainage is scheduled. ms-val-431 1 9 CT-guided percutaneous drainage is scheduled. ms-val-431 1 9 CT-guided percutaneous drainage is scheduled.
ms-val-432 1 -1 nan ms-val-432 1 -1 nan ms-val-432 1 -1 nan
ms-val-433 1 8 Mom has been applying a topical emollient. ms-val-433 1 8 Mom has been applying a topical emollient. ms-val-433 1 8 Mom has been applying a topical emollient.
ms-val-434 1 -1 nan ms-val-434 1 -1 nan ms-val-434 1 -1 nan
ms-val-435 1 6 Provided patient with education after she had a physical exam and based on imaging findings. ms-val-435 1 6 Provided patient with education after she had a physical exam and based on imaging findings. ms-val-435 1 6 Provided patient with education after she had a physical exam and based on imaging findings.
ms-val-436 1 -1 nan ms-val-436 1 -1 nan ms-val-436 1 -1 nan
ms-val-437 1 6 Patient was recommended to start aspirin therapy. ms-val-437 1 6 Patient was recommended to start aspirin therapy. ms-val-437 1 6 Patient was recommended to start aspirin therapy.
ms-val-438 1 -1 nan ms-val-438 1 -1 nan ms-val-438 1 -1 nan
ms-val-439 1 4 CT of the head is obtained after neurologic exam reveals right upper and lower extremity weakness and an asymmetric smile. ms-val-439 1 4 CT of the head is obtained after neurologic exam reveals right upper and lower extremity weakness and an asymmetric smile. ms-val-439 1 4 CT of the head is obtained after neurologic exam reveals right upper and lower extremity weakness and an asymmetric smile.
ms-val-440 1 -1 nan ms-val-440 1 -1 nan ms-val-440 1 -1 nan
ms-val-441 1 6 After confirming the diagnosis via echocardiography, an indomethacin infusion is administered. ms-val-441 1 6 After confirming the diagnosis via echocardiography, an indomethacin infusion is administered. ms-val-441 1 6 After confirming the diagnosis via echocardiography, an indomethacin infusion is administered.
ms-val-442 1 -1 nan ms-val-442 1 -1 nan ms-val-442 1 -1 nan
ms-val-443 1 13 Patient was reassured about his condition based on the following findings. ms-val-443 1 13 Patient was reassured about his condition based on the following findings. ms-val-443 1 13 Patient was reassured about his condition based on the following findings.
ms-val-444 1 -1 nan ms-val-444 1 -1 nan ms-val-444 1 -1 nan
ms-val-445 1 14 In addition to initiating heparin therapy, a balloon catheter embolectomy is scheduled. ms-val-445 1 14 In addition to initiating heparin therapy, a balloon catheter embolectomy is scheduled. ms-val-445 1 14 In addition to initiating heparin therapy, a balloon catheter embolectomy is scheduled.
ms-val-446 1 -1 nan ms-val-446 1 -1 nan ms-val-446 1 -1 nan
ms-val-447 1 10 Unsynchronized cardioversion was administered to the patient after an ECG was conducted. ms-val-447 1 10 Unsynchronized cardioversion was administered to the patient after an ECG was conducted. ms-val-447 1 10 Unsynchronized cardioversion was administered to the patient after an ECG was conducted.
ms-val-448 1 -1 nan ms-val-448 1 -1 nan ms-val-448 1 -1 nan
ms-val-449 1 18 Started cART and scheduled cesarean delivery at 38 weeks gestation. ms-val-449 1 18 Started cART and scheduled cesarean delivery at 38 weeks gestation. ms-val-449 1 18 Started cART and scheduled cesarean delivery at 38 weeks gestation.
ms-val-450 1 -1 nan ms-val-450 1 -1 nan ms-val-450 1 -1 nan
ms-val-451 1 6 MRI is obtained after physical exam is notable for weak leg flexion bilaterally along with decreased anal sphincter tone. ms-val-451 1 6 MRI is obtained after physical exam is notable for weak leg flexion bilaterally along with decreased anal sphincter tone. ms-val-451 1 6 MRI is obtained after physical exam is notable for weak leg flexion bilaterally along with decreased anal sphincter tone.
ms-val-452 1 -1 nan ms-val-452 1 -1 nan ms-val-452 1 -1 nan
ms-val-453 1 9 Diltiazem is administered to the patient. ms-val-453 1 9 Diltiazem is administered to the patient. ms-val-453 1 9 Diltiazem is administered to the patient.
ms-val-454 1 -1 nan ms-val-454 1 -1 nan ms-val-454 1 -1 nan
ms-val-455 1 9 In addition to intravenous fluid resuscitation, CT angiography was performed based on the following exam. ms-val-455 1 9 In addition to intravenous fluid resuscitation, CT angiography was performed based on the following exam. ms-val-455 1 9 In addition to intravenous fluid resuscitation, CT angiography was performed based on the following exam.
ms-val-456 1 -1 nan ms-val-456 1 -1 nan ms-val-456 1 -1 nan
ms-val-457 1 2 Surgical excision with 1-2 cm safety margins and sentinel lymph node study is performed. ms-val-457 1 2 Surgical excision with 1-2 cm safety margins and sentinel lymph node study is performed. ms-val-457 1 2 Surgical excision with 1-2 cm safety margins and sentinel lymph node study is performed.
ms-val-458 1 -1 nan ms-val-458 1 -1 nan ms-val-458 1 -1 nan
ms-val-459 1 11 Based on imaging, patient was scheduled for a surgical resection. ms-val-459 1 11 Based on imaging, patient was scheduled for a surgical resection. ms-val-459 1 11 Based on imaging, patient was scheduled for a surgical resection.
ms-val-460 1 -1 nan ms-val-460 1 -1 nan ms-val-460 1 -1 nan
ms-val-461 1 5 Ultrasound findings are shown in Figure A and Figure B, and her ÃŸ-hCG is 227,183 mIU/mL. Dilation and curettage is initiated with serial serum ÃŸ-hCG levels. ms-val-461 1 5 Ultrasound findings are shown in Figure A and Figure B, and her ÃŸ-hCG is 227,183 mIU/mL. Dilation and curettage is initiated with serial serum ÃŸ-hCG levels. ms-val-461 1 5 Ultrasound findings are shown in Figure A and Figure B, and her ÃŸ-hCG is 227,183 mIU/mL. Dilation and curettage is initiated with serial serum ÃŸ-hCG levels.
ms-val-462 1 -1 nan ms-val-462 1 -1 nan ms-val-462 1 -1 nan
ms-val-463 1 6 Whole blood, fresh frozen plasma, and platelet concentrate are transfused in a 1:1:1 ratio after repeat laboratory studies now show a hemoglobin concentration of 12.4 g/dL, platelet count of 102,000/mm3, prothrombin time of 26 seconds (INR=1.8), and activated partial thromboplastin time of 63 seconds. ms-val-463 1 6 Whole blood, fresh frozen plasma, and platelet concentrate are transfused in a 1:1:1 ratio after repeat laboratory studies now show a hemoglobin concentration of 12.4 g/dL, platelet count of 102,000/mm3, prothrombin time of 26 seconds (INR=1.8), and activated partial thromboplastin time of 63 seconds. ms-val-463 1 6 Whole blood, fresh frozen plasma, and platelet concentrate are transfused in a 1:1:1 ratio after repeat laboratory studies now show a hemoglobin concentration of 12.4 g/dL, platelet count of 102,000/mm3, prothrombin time of 26 seconds (INR=1.8), and activated partial thromboplastin time of 63 seconds.
ms-val-464 1 -1 nan ms-val-464 1 -1 nan ms-val-464 1 -1 nan
ms-val-465 1 12 Patient is prescribed an oral gabapentin. ms-val-465 1 12 Patient is prescribed an oral gabapentin. ms-val-465 1 12 Patient is prescribed an oral gabapentin.
ms-val-466 1 12 CT scan of the chest is required. ms-val-466 1 12 CT scan of the chest is required. ms-val-466 1 12 CT scan of the chest is required.
ms-val-467 1 -1 nan ms-val-467 1 -1 nan ms-val-467 1 -1 nan
ms-val-468 1 10 Cesarean section was performed. ms-val-468 1 10 Cesarean section was performed. ms-val-468 1 10 Cesarean section was performed.
ms-val-469 1 -1 nan ms-val-469 1 -1 nan ms-val-469 1 -1 nan
ms-val-470 1 9 Stretching program is required. ms-val-470 1 9 Stretching program is required. ms-val-470 1 9 Stretching program is required.
ms-val-471 1 -1 nan ms-val-471 1 -1 nan ms-val-471 1 -1 nan
ms-val-472 1 13 An ultrasound of the abdomen is ordered. ms-val-472 1 13 An ultrasound of the abdomen is ordered. ms-val-472 1 13 An ultrasound of the abdomen is ordered.
ms-val-473 1 -1 nan ms-val-473 1 -1 nan ms-val-473 1 -1 nan
ms-val-474 1 12 Repeat abdominal ultrasound in 6 months planned after the following results. ms-val-474 1 12 Repeat abdominal ultrasound in 6 months planned after the following results. ms-val-474 1 12 Repeat abdominal ultrasound in 6 months planned after the following results.
ms-val-475 1 -1 nan ms-val-475 1 -1 nan ms-val-475 1 -1 nan
ms-val-476 1 5 Calcium gluconate is administered. ms-val-476 1 5 Calcium gluconate is administered. ms-val-476 1 5 Calcium gluconate is administered.
ms-val-477 1 -1 nan ms-val-477 1 -1 nan ms-val-477 1 -1 nan
ms-val-478 1 10 Surgical debridement is performed. ms-val-478 1 10 Surgical debridement is performed. ms-val-478 1 10 Surgical debridement is performed.
ms-val-479 1 -1 nan ms-val-479 1 -1 nan ms-val-479 1 -1 nan
ms-val-480 1 32 Treat with sofosbuvir and ledipasvir therapy. ms-val-480 1 32 Treat with sofosbuvir and ledipasvir therapy. ms-val-480 1 32 Treat with sofosbuvir and ledipasvir therapy.
ms-val-481 1 11 Transfusion of packed red blood cells was given. ms-val-481 1 11 Transfusion of packed red blood cells was given. ms-val-481 1 11 Transfusion of packed red blood cells was given.
ms-val-482 1 -1 nan ms-val-482 1 -1 nan ms-val-482 1 -1 nan
ms-val-483 1 17 Labor induction is recommended. ms-val-483 1 17 Labor induction is recommended. ms-val-483 1 17 Labor induction is recommended.
ms-val-484 1 -1 nan ms-val-484 1 -1 nan ms-val-484 1 -1 nan
ms-val-485 1 7 Fluoxetine is recommended. ms-val-485 1 7 Fluoxetine is recommended. ms-val-485 1 7 Fluoxetine is recommended.
ms-val-486 1 -1 nan ms-val-486 1 -1 nan ms-val-486 1 -1 nan
ms-val-487 1 2 The physician prescribes a drug that blocks peptide transfer by binding to the 50S ribosomal subunit called clindamycin. ms-val-487 1 2 The physician prescribes a drug that blocks peptide transfer by binding to the 50S ribosomal subunit called clindamycin. ms-val-487 1 2 The physician prescribes a drug that blocks peptide transfer by binding to the 50S ribosomal subunit called clindamycin.
ms-val-488 1 -1 nan ms-val-488 1 -1 nan ms-val-488 1 -1 nan
ms-val-489 1 5 Patient is advised to discontinue multivitamin. ms-val-489 1 5 Patient is advised to discontinue multivitamin. ms-val-489 1 5 Patient is advised to discontinue multivitamin.
ms-val-490 1 -1 nan ms-val-490 1 -1 nan ms-val-490 1 -1 nan
ms-val-491 1 9 Patient was prescribed exenatide to take in addition to her current medication regimen. ms-val-491 1 9 Patient was prescribed exenatide to take in addition to her current medication regimen. ms-val-491 1 9 Patient was prescribed exenatide to take in addition to her current medication regimen.
ms-val-492 1 5 Phentolamine was administered. ms-val-492 1 5 Phentolamine was administered. ms-val-492 1 5 Phentolamine was administered.
ms-val-493 1 -1 nan ms-val-493 1 -1 nan ms-val-493 1 -1 nan
ms-val-494 1 13 Sodium bicarbonate was administered to the patient. ms-val-494 1 13 Sodium bicarbonate was administered to the patient. ms-val-494 1 13 Sodium bicarbonate was administered to the patient.
ms-val-495 1 3 Riluzole would likely slow the progression of symptoms. ms-val-495 1 3 Riluzole would likely slow the progression of symptoms. ms-val-495 1 3 Riluzole would likely slow the progression of symptoms.
ms-val-496 1 -1 nan ms-val-496 1 -1 nan ms-val-496 1 -1 nan
ms-val-497 1 15 Patient is prescribed ibuprofen. ms-val-497 1 15 Patient is prescribed ibuprofen. ms-val-497 1 15 Patient is prescribed ibuprofen.
ms-val-498 1 3 Desmopressin was administered. ms-val-498 1 3 Desmopressin was administered. ms-val-498 1 3 Desmopressin was administered.
ms-val-499 1 -1 nan ms-val-499 1 -1 nan ms-val-499 1 -1 nan
ms-val-500 1 11 Pramipexole was prescribed to the patient. ms-val-500 1 11 Pramipexole was prescribed to the patient. ms-val-500 1 11 Pramipexole was prescribed to the patient.
ms-val-501 1 -1 nan ms-val-501 1 -1 nan ms-val-501 1 -1 nan
ms-val-502 1 7 Buspirone is recommended. ms-val-502 1 7 Buspirone is recommended. ms-val-502 1 7 Buspirone is recommended.
ms-val-503 1 -1 nan ms-val-503 1 -1 nan ms-val-503 1 -1 nan
ms-val-504 1 7 Terazosin was prescribed to the patient. ms-val-504 1 7 Terazosin was prescribed to the patient. ms-val-504 1 7 Terazosin was prescribed to the patient.
ms-val-505 1 -1 nan ms-val-505 1 -1 nan ms-val-505 1 -1 nan
ms-val-506 1 7 Topical estrogen cream was recommended. ms-val-506 1 7 Topical estrogen cream was recommended. ms-val-506 1 7 Topical estrogen cream was recommended.
ms-val-507 1 -1 nan ms-val-507 1 -1 nan ms-val-507 1 -1 nan
ms-val-508 1 6 Amlodipine was administered. ms-val-508 1 6 Amlodipine was administered. ms-val-508 1 6 Amlodipine was administered.
ms-val-509 1 -1 nan ms-val-509 1 -1 nan ms-val-509 1 -1 nan
ms-val-510 1 4 Oral azithromycin is recommended. ms-val-510 1 4 Oral azithromycin is recommended. ms-val-510 1 4 Oral azithromycin is recommended.
ms-val-511 1 -1 nan ms-val-511 1 -1 nan ms-val-511 1 -1 nan
ms-val-512 1 4 Flecainide is prescribed. ms-val-512 1 4 Flecainide is prescribed. ms-val-512 1 4 Flecainide is prescribed.
ms-val-513 1 -1 nan ms-val-513 1 -1 nan ms-val-513 1 -1 nan
ms-val-514 1 7 Magnesium sulfate is prescribed. ms-val-514 1 7 Magnesium sulfate is prescribed. ms-val-514 1 7 Magnesium sulfate is prescribed.
ms-val-515 1 -1 nan ms-val-515 1 -1 nan ms-val-515 1 -1 nan
ms-val-516 1 7 These findings are the result of taking the fluconazole, which was prescribed to him recently. ms-val-516 1 7 These findings are the result of taking the fluconazole, which was prescribed to him recently. ms-val-516 1 7 These findings are the result of taking the fluconazole, which was prescribed to him recently.
ms-val-517 1 -1 nan ms-val-517 1 -1 nan ms-val-517 1 -1 nan
ms-val-518 1 7 Patient is given fexofenadine after his nasal exam shows clear, serous secretions, with edematous and erythematous mucosa and turbinates. ms-val-518 1 7 Patient is given fexofenadine after his nasal exam shows clear, serous secretions, with edematous and erythematous mucosa and turbinates. ms-val-518 1 7 Patient is given fexofenadine after his nasal exam shows clear, serous secretions, with edematous and erythematous mucosa and turbinates.
ms-val-519 1 -1 nan ms-val-519 1 -1 nan ms-val-519 1 -1 nan
ms-val-520 1 5 The patient is started on cabergoline. ms-val-520 1 5 The patient is started on cabergoline. ms-val-520 1 5 The patient is started on cabergoline.
ms-val-521 1 -1 nan ms-val-521 1 -1 nan ms-val-521 1 -1 nan
ms-val-522 1 6 After examining the patient, she was prescribed metoclopramide. ms-val-522 1 6 After examining the patient, she was prescribed metoclopramide. ms-val-522 1 6 After examining the patient, she was prescribed metoclopramide.
ms-val-523 1 -1 nan ms-val-523 1 -1 nan ms-val-523 1 -1 nan
ms-val-524 1 10 Topical ofloxacin is prescribed. ms-val-524 1 10 Topical ofloxacin is prescribed. ms-val-524 1 10 Topical ofloxacin is prescribed.
ms-val-525 1 -1 nan ms-val-525 1 -1 nan ms-val-525 1 -1 nan
ms-val-526 1 5 Metronidazole was prescribed to the patient. ms-val-526 1 5 Metronidazole was prescribed to the patient. ms-val-526 1 5 Metronidazole was prescribed to the patient.
ms-val-527 1 5 Patient was prescribed zaleplon. ms-val-527 1 5 Patient was prescribed zaleplon. ms-val-527 1 5 Patient was prescribed zaleplon.
ms-val-528 1 6 Patient is given topical erythromycin after ophthalmic examination shows edema of both eyelids, bilateral conjunctival injection, and a thin purulent discharge. ms-val-528 1 6 Patient is given topical erythromycin after ophthalmic examination shows edema of both eyelids, bilateral conjunctival injection, and a thin purulent discharge. ms-val-528 1 6 Patient is given topical erythromycin after ophthalmic examination shows edema of both eyelids, bilateral conjunctival injection, and a thin purulent discharge.
ms-val-529 1 -1 nan ms-val-529 1 -1 nan ms-val-529 1 -1 nan
ms-val-530 1 15 Haloperidol was administered to the patient. ms-val-530 1 15 Haloperidol was administered to the patient. ms-val-530 1 15 Haloperidol was administered to the patient.
ms-val-531 1 -1 nan ms-val-531 1 -1 nan ms-val-531 1 -1 nan
ms-val-532 1 10 After reviewing labs and imaging, intravenous nitroprusside was administered to the patient. ms-val-532 1 10 After reviewing labs and imaging, intravenous nitroprusside was administered to the patient. ms-val-532 1 10 After reviewing labs and imaging, intravenous nitroprusside was administered to the patient.
ms-val-533 1 -1 nan ms-val-533 1 -1 nan ms-val-533 1 -1 nan
ms-val-534 1 24 Phlebotomy is required. ms-val-534 1 24 Phlebotomy is required. ms-val-534 1 24 Phlebotomy is required.
ms-val-535 1 6 Her serum triglyceride concentration is 5 mg/dL. Restriction of long-chain fatty acids is recommended. ms-val-535 1 6 Her serum triglyceride concentration is 5 mg/dL. Restriction of long-chain fatty acids is recommended. ms-val-535 1 6 Her serum triglyceride concentration is 5 mg/dL. Restriction of long-chain fatty acids is recommended.
ms-val-536 1 -1 nan ms-val-536 1 -1 nan ms-val-536 1 -1 nan
ms-val-537 1 6 The patient is started on a drug that competes with androgens for interaction with the testosterone receptors called flutamide. ms-val-537 1 6 The patient is started on a drug that competes with androgens for interaction with the testosterone receptors called flutamide. ms-val-537 1 6 The patient is started on a drug that competes with androgens for interaction with the testosterone receptors called flutamide.
ms-val-538 1 -1 nan ms-val-538 1 -1 nan ms-val-538 1 -1 nan
ms-val-539 1 5 Valproate was administered. ms-val-539 1 5 Valproate was administered. ms-val-539 1 5 Valproate was administered.
ms-val-540 1 6 Oral beta carotene supplementation is initiated. ms-val-540 1 6 Oral beta carotene supplementation is initiated. ms-val-540 1 6 Oral beta carotene supplementation is initiated.
ms-val-541 1 -1 nan ms-val-541 1 -1 nan ms-val-541 1 -1 nan
ms-val-542 1 31 Cesarean section is initiated. ms-val-542 1 31 Cesarean section is initiated. ms-val-542 1 31 Cesarean section is initiated.
ms-val-543 1 6 Patient's guardian is advised to start patient on Laxatives and stool softeners. ms-val-543 1 6 Patient's guardian is advised to start patient on Laxatives and stool softeners. ms-val-543 1 6 Patient's guardian is advised to start patient on Laxatives and stool softeners.
ms-val-544 1 4 Chlorpromazine is prescribed. ms-val-544 1 4 Chlorpromazine is prescribed. ms-val-544 1 4 Chlorpromazine is prescribed.
ms-val-545 1 -1 nan ms-val-545 1 -1 nan ms-val-545 1 -1 nan
ms-val-546 1 6 The patient is started on nitrofurantoin. ms-val-546 1 6 The patient is started on nitrofurantoin. ms-val-546 1 6 The patient is started on nitrofurantoin.
ms-val-547 1 -1 nan ms-val-547 1 -1 nan ms-val-547 1 -1 nan
ms-val-548 1 9 Patient is prescribed metoprolol. ms-val-548 1 9 Patient is prescribed metoprolol. ms-val-548 1 9 Patient is prescribed metoprolol.
ms-val-549 1 6 Tamsulosin and ciprofloxacin were prescribed to the patient after urinalysis revealed trace leukocyte esterase and negative nitrite, negative blood, and no bacteria on microscopy. ms-val-549 1 6 Tamsulosin and ciprofloxacin were prescribed to the patient after urinalysis revealed trace leukocyte esterase and negative nitrite, negative blood, and no bacteria on microscopy. ms-val-549 1 6 Tamsulosin and ciprofloxacin were prescribed to the patient after urinalysis revealed trace leukocyte esterase and negative nitrite, negative blood, and no bacteria on microscopy.
ms-val-550 1 -1 nan ms-val-550 1 -1 nan ms-val-550 1 -1 nan
ms-val-551 1 18 Oral prednisone is given. ms-val-551 1 18 Oral prednisone is given. ms-val-551 1 18 Oral prednisone is given.
ms-val-552 1 -1 nan ms-val-552 1 -1 nan ms-val-552 1 -1 nan
ms-val-553 1 8 After examining the patient and completing labs, he was prescribed cephalexin therapy. ms-val-553 1 8 After examining the patient and completing labs, he was prescribed cephalexin therapy. ms-val-553 1 8 After examining the patient and completing labs, he was prescribed cephalexin therapy.
ms-val-554 1 -1 nan ms-val-554 1 -1 nan ms-val-554 1 -1 nan
ms-val-555 1 13 Intravenous immunoglobulin is required. ms-val-555 1 13 Intravenous immunoglobulin is required. ms-val-555 1 13 Intravenous immunoglobulin is required.
ms-val-556 1 -1 nan ms-val-556 1 -1 nan ms-val-556 1 -1 nan
ms-val-557 1 7 Protein C concentrate is administered. ms-val-557 1 7 Protein C concentrate is administered. ms-val-557 1 7 Protein C concentrate is administered.
ms-val-558 1 9 rash on his arms and legs, as shown in Figure A. Patient was treated with niacin. ms-val-558 1 9 rash on his arms and legs, as shown in Figure A. Patient was treated with niacin. ms-val-558 1 9 rash on his arms and legs, as shown in Figure A. Patient was treated with niacin.
ms-val-559 1 11 Intravenous immunoglobulin (IVIG) was given to further evaluate after labs and lumbar puncture revealed the following. ms-val-559 1 11 Intravenous immunoglobulin (IVIG) was given to further evaluate after labs and lumbar puncture revealed the following. ms-val-559 1 11 Intravenous immunoglobulin (IVIG) was given to further evaluate after labs and lumbar puncture revealed the following.
ms-val-560 1 -1 nan ms-val-560 1 -1 nan ms-val-560 1 -1 nan
ms-val-561 1 4 Treatment with a muscarinic antagonist is begun. ms-val-561 1 4 Treatment with a muscarinic antagonist is begun. ms-val-561 1 4 Treatment with a muscarinic antagonist is begun.
ms-val-562 1 -1 nan ms-val-562 1 -1 nan ms-val-562 1 -1 nan
ms-val-563 1 5 Patient was treated with methylprednisolone. ms-val-563 1 5 Patient was treated with methylprednisolone. ms-val-563 1 5 Patient was treated with methylprednisolone.
ms-val-564 1 10 Patient was recommended lying in the left lateral decubitus position to reverse these symptoms in the future and she was discharged home. ms-val-564 1 10 Patient was recommended lying in the left lateral decubitus position to reverse these symptoms in the future and she was discharged home. ms-val-564 1 10 Patient was recommended lying in the left lateral decubitus position to reverse these symptoms in the future and she was discharged home.
ms-val-565 1 5 Corticosteroid is prescribed to the patient after his laboratory tests are notable for an ESR of 52 mm/hr ms-val-565 1 5 Corticosteroid is prescribed to the patient after his laboratory tests are notable for an ESR of 52 mm/hr ms-val-565 1 5 Corticosteroid is prescribed to the patient after his laboratory tests are notable for an ESR of 52 mm/hr
ms-val-566 1 -1 nan ms-val-566 1 -1 nan ms-val-566 1 -1 nan
ms-val-567 1 10 Patient is advised to take rifaximin. ms-val-567 1 10 Patient is advised to take rifaximin. ms-val-567 1 10 Patient is advised to take rifaximin.
ms-val-568 1 -1 nan ms-val-568 1 -1 nan ms-val-568 1 -1 nan
ms-val-569 1 16 Positive Magnesium is administered during the patient's evaluation, after she experiences 1 episode of tonic-clonic motions which persisted for 5 minutes. ms-val-569 1 16 Positive Magnesium is administered during the patient's evaluation, after she experiences 1 episode of tonic-clonic motions which persisted for 5 minutes. ms-val-569 1 16 Positive Magnesium is administered during the patient's evaluation, after she experiences 1 episode of tonic-clonic motions which persisted for 5 minutes.
ms-val-570 1 -1 nan ms-val-570 1 -1 nan ms-val-570 1 -1 nan
ms-val-571 1 11 On physical exam, you note bilateral expiratory wheezing and lesions within the nasal cavity, shown in Figure A. Patient was prescribed montelukast. ms-val-571 1 11 On physical exam, you note bilateral expiratory wheezing and lesions within the nasal cavity, shown in Figure A. Patient was prescribed montelukast. ms-val-571 1 11 On physical exam, you note bilateral expiratory wheezing and lesions within the nasal cavity, shown in Figure A. Patient was prescribed montelukast.
ms-val-572 1 7 Patient is started on lactulose. ms-val-572 1 7 Patient is started on lactulose. ms-val-572 1 7 Patient is started on lactulose.
ms-val-573 1 -1 nan ms-val-573 1 -1 nan ms-val-573 1 -1 nan
